The present disclosure relates generally to systems, apparatus, and methods for collecting and transporting urine away from the body of a person or animal.
The embodiments described herein relate generally to collecting and transporting urine away from the body of a person or animal. In various circumstances, a person or animal may have limited or impaired mobility such that typical urination processes are challenging or impossible. For example, a person may experience or have a disability that impairs mobility. A person may have restricted travel conditions such as those experienced by pilots, drivers, and workers in hazardous areas. Additionally, sometimes urine collection is needed for monitoring purposes or clinical testing.
Urinary catheters, such as a Foley catheter, can be used to address some of these circumstances, such as incontinence. Unfortunately, however, urinary catheters can be uncomfortable, painful, and can lead to complications, such as infections. Additionally, bed pans, which are receptacles used for the toileting of bedridden patients, such as those in a health care facility, are sometimes used. Bed pans, however, can be prone to discomfort, spills, and other hygiene issues.
Thus, there is a need for a device capable of collecting urine from a person or animal comfortably and with minimal contamination of the user and/or the surrounding area.
A system is disclosed that is suitable for collecting and transporting urine away from the body of a person or animal. The disclosed system includes an assembly that may include a fluid impermeable casing having a fluid reservoir at a first end, a fluid outlet at a second end, and a longitudinally extending fluid impermeable layer coupled to the fluid reservoir and the fluid outlet and defining a longitudinally elongated opening between the fluid reservoir and the fluid outlet. The assembly can further include a fluid permeable support disposed within the casing with a portion extending across the elongated opening, and a fluid permeable membrane disposed on the support and covering at least the portion of the support that extends across the elongated opening, so that the membrane is supported on the support and disposed across the elongated opening. The assembly can further include a tube having a first end disposed in the reservoir and extending behind at least the portion of the support and the portion of the membrane disposed across the elongated opening and extending through the fluid outlet to a second, fluid discharge end. The assembly can be configured to be disposed with the opening adjacent to a urethral opening of a user, to receive urine discharged from the urethral opening through the opening of the fluid impermeable layer, the membrane, the support, and into the reservoir, and to have the received urine withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
A system is disclosed that is suitable for collecting and transporting urine away from the body of a person or animal. The disclosed system includes an assembly that may include a fluid impermeable casing having a fluid reservoir at a first end, a fluid outlet at a second end, and a longitudinally extending fluid impermeable layer coupled to the fluid reservoir and the fluid outlet and defining a longitudinally elongated opening between the fluid reservoir and the fluid outlet. The assembly can further include a fluid permeable support disposed within the casing with a portion extending across the elongated opening, and a fluid permeable membrane disposed on the support and covering at least the portion of the support that extends across the elongated opening, so that the membrane is supported on the support and disposed across the elongated opening. The assembly can further include a tube having a first end disposed in the reservoir and extending behind at least the portion of the support and the portion of the membrane disposed across the elongated opening and extending through the fluid outlet to a second, fluid discharge end. The assembly can be configured to be disposed with the opening adjacent to a urethral opening of a user, to receive urine discharged from the urethral opening through the opening of the fluid impermeable layer, the membrane, the support, and into the reservoir, and to have the received urine withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
In some embodiments, a method includes disposing in operative relationship with the urethral opening of a female user, a urine collecting apparatus. The urine collecting apparatus can include a fluid impermeable casing having a fluid reservoir at a first end, a fluid outlet at a second end, and a longitudinally extending fluid impermeable layer coupled to the fluid reservoir and the fluid outlet and defining a longitudinally elongated opening between the fluid reservoir and the fluid outlet. The urine collecting apparatus can also include a fluid permeable support disposed within the casing with a portion extending across the elongated opening, a fluid permeable membrane disposed on the support and covering at least the portion of the support that extends across the elongated opening, so that the membrane is supported on the support and disposed across the elongated opening, and a tube having a first end disposed in the reservoir and extending behind at least the portion of the support and the portion of the membrane disposed across the elongated opening and extending through the fluid outlet to a second, fluid discharge end. The operative relationship can include the opening being adjacent to the urethral opening. The method can further include allowing urine discharged from the urethral opening to be received through the opening of the fluid impermeable layer, the membrane, the support, and into the reservoir; and allowing the received urine to be withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
In some embodiments, an apparatus includes a fluid permeable support disposed between a fluid permeable membrane and a fluid reservoir, and a fluid outlet. The apparatus can be configured to be disposed with a portion of the fluid permeable membrane adjacent to a urethral opening of a user, to receive urine discharged from the urethral opening through the fluid permeable membrane, the fluid permeable support, and into the reservoir, and to have the received urine withdrawn from the reservoir via the outlet.
As used in this specification, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, the term “a member” is intended to mean a single member or a combination of members, “a material” is intended to mean one or more materials, or a combination thereof.
The embodiments described herein can be formed or constructed of one or more biocompatible materials. Examples of suitable biocompatible materials include metals, ceramics, or polymers. Examples of suitable metals include pharmaceutical grade stainless steel, gold, titanium, nickel, iron, platinum, tin, chromium, copper, and/or alloys thereof. Examples of polymers include nylons, polyesters, polycarbonates, polyacrylates, polymers of ethylene-vinyl acetates and other acyl substituted cellulose acetates, non-degradable polyurethanes, polystyrenes, polyvinyl chloride, polyvinyl fluoride, poly(vinyl imidazole), chlorosulphonate polyolefins, polyethylene oxide, polyethylene terephthalate (PET), polytetrafluoroethylene (PTFE), and/or blends and copolymers thereof.
The permeable membrane 130 can be formed of a material that has permeable properties with respect to liquids such as urine. The permeable properties can be wicking, capillary action, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “wicking.” The permeable membrane 130 can have a high absorptive rate and a high permeation rate such that urine can be rapidly absorbed by the permeable membrane 130 and/or transported through the permeable membrane 130. In some implementations, the permeable membrane 130 can be a ribbed knit fabric. In some implementations, the permeable membrane 130 can include and/or have the moisture-wicking characteristic of gauze, felt, terrycloth, thick tissue paper, and/or a paper towel. In some implementations, the permeable membrane 130 can be soft and/or minimally abrasive such that the permeable membrane 130 does not irritate the skin of the user. The permeable membrane 130 can be configured to wick fluid away from the urethral opening and/or the skin of the user such that the dampness of the skin of the user is lessened and infections are prevented. Additionally, the wicking properties of the permeable membrane 130 can help prevent urine from leaking or flowing beyond the assembly onto, for example, a bed. In some implementations, the permeable membrane 130 can be formed of fine denier polyester fibers coated with a thermoplastic water-based binder system. The tensile with the Webb direction can be, for example, about 45 lbs/inch2 measured using an Instron test method. The weight per permeable membrane can be, for example, about 12 grams measured using the Mettle Gram Scale. The thickness per ten permeable membrane can be, for example, about 2.5″, measured using the Gustin-Bacon/Measure-Matic.
The permeable support 140 can be positioned relative to the permeable membrane 130 such that the permeable support 140 maintains the permeable membrane 130 in a particular shape and allows for fluid, such as, for example, urine, to flow through the permeable membrane 130, through the permeable support 140, and into the reservoir 110. In some implementations, the permeable support 140 can be configured to maintain the permeable membrane 130 against or near a urethral opening of a user. For example, the permeable support 140 can include a portion having a curved shape in contact with the permeable membrane 130 such that the permeable membrane 130 is also curved, thus creating a comfortable and secure interface for engagement with a user's urethral opening and/or the area of the body near the urethral opening. In some implementations, the permeable support 140 can be made of a rigid plastic. In some implementations, the permeable support 140 can have any suitable shape and be formed of any suitable material. For example, the permeable support 140 can be flexible. Additionally, the permeable support 140 can be formed of aluminum, a composite of plastic and aluminum, some other metal and/or a composite of plastic and another metal. In some implementations, the permeable support 140 can be formed of a natural material, such as, for example, plant fibers (e.g., Greener Clean manufactured by 3M®). The natural material can include openings that allow fluid to flow through the natural material. In some embodiments, the permeable support 140 can be cylindrical and can define a lumen. In some embodiments, the permeable support 140 can be formed of perforated coated paper, such as tubular waxed paper.
The permeable support 140 can define one or more openings (e.g., an array of openings) to allow for fluid flow from the permeable membrane 130 to the reservoir 110. In some implementations, the permeable support 140 can be formed as a tube, a cylinder, or a curved cylinder with one or more openings. In some implementations, the permeable support 140 can include membrane supports (e.g., struts) extending across an opening such that the opening is divided into an array of distinct slot-shaped openings. The membrane supports can be used to support the permeable membrane 130. For example, the membrane supports can maintain the shape of the permeable membrane 130 against or near a user's urethral opening such that urine flowing from the urethral opening contacts and travels through the permeable membrane 130. In some implementations, the permeable support 140 can define several openings having a variety of shapes, such as a plurality of round openings. In some implementations, the permeable support 140 can be formed as a cylinder of spun plastic (e.g., non-woven permeable nylon and polyester webbing) such that the permeable support 140 can have many openings. For example, a rectangular portion of spun plastic can be folded or rolled into a cylinder shape for use in the assembly 102. In some implementations, the permeable support 140 can be formed of a porous material. For example, the permeable support 140 can be a porous glass tubular container defining frits. In other implementations, the permeable support 140 can define an opening in a sidewall of the permeable support 140 and the sidewall can be covered by a mesh screen defining many smaller openings.
The reservoir 110 can be any suitable shape and/or size capable of collecting fluid transported through the permeable support 140. In some implementations, the reservoir 110 can be sized such that the reservoir is capable of collecting and temporarily holding a large or small amount of urine until the urine can be removed from the reservoir via the outlet 120. For example, the reservoir 110 can be sized such that the reservoir 110 is configured to hold a small amount of urine as may be released due to incontinence. In some implementations, the reservoir 110 can be sized such that the reservoir 110 is configured to hold a large amount of urine as may be released during voiding of a full bladder. In some implementations, the reservoir 110 can be sized such that the reservoir is configured to collect and hold a small or large amount of urine while the urine is simultaneously removed via, for example, gravity and/or a pump, such as the vacuum source 170. Said another way, the reservoir 110 can function as a sump and be sized such that the reservoir 110 can form a portion of a passageway for urine from the permeable membrane 130, through the permeable support 140, through the reservoir 110, and out of the outlet 120. In a condition where the flow rate of urine into the assembly 102 via the permeable membrane 130 is greater than the flow rate of urine through the discharge line 122, a temporary backup of urine may occur in the reservoir 110. Thus, the reservoir 110 can be sized to contain a volume of fluid that may temporarily accumulate due to the difference in flow rates into and out of the assembly 102.
Although the outlet 120 is shown as extending from the side of the reservoir 110, in some implementations, the outlet 120 can extend from the bottom of the reservoir 110. Positioning the outlet 120 lower in the reservoir 110 such that less or no urine can pool at the bottom of the reservoir 110 can allow for urine to be removed from the reservoir 110 more quickly and/or completely. In other implementations, the outlet 120 can be positioned within the reservoir such that at least a portion of tubing associated with the outlet 120 extends from the top of the reservoir 110. For example, a portion of tubing associated with the outlet 120 can extend from the top of the reservoir 110 through at least a portion of the permeable support 140 (e.g., a central channel) and, optionally, through at least a portion of the permeable membrane 130. In such an implementation, the outlet 120 can be positioned a distance from the reservoir 110 such that fluid can flow from the reservoir, through the tubing associated with the outlet 120, and from the outlet 120. In such implementations, positioning the reservoir end of the tubing associated with the outlet 120 towards the bottom of the reservoir 110 such that less or no urine can pool at the bottom of the reservoir 110 can allow for urine to be removed from the reservoir 110 more quickly and/or completely. In some implementations, the tubing associated with the outlet 120 can be precurved at least in the portion extending through the permeable support 140.
In some implementations, the reservoir 110 and the permeable support 140 can be formed as separate components and coupled together during assembly. In some implementations, the permeable support 140 and the reservoir 110 can be formed as a cylindrical integral, unitary structure that is sealed at one end by a closed end of the reservoir 110 and at the other end by a closed end of the permeable support 140.
The external receptacle 160, via the discharge line 122, can collect fluid exiting the reservoir 110 through the outlet 120. The external receptacle 160 can be a sealed container. In some implementations, the external receptacle 160 can be disposable. In some implementations, the external receptacle 160 can be configured to be sterilized and reused.
In some implementations, gravity can cause fluid within the reservoir 110 to follow a flow path (i.e., the fluid flow path including the outlet 120 and the discharge line 122) from the reservoir 110 to the external receptacle 160. In some implementations, the vacuum source 170 can assist and/or provide the pressure differential needed to draw fluid voided from the urethral opening of a user into the permeable support 140, into the reservoir 110, and from the reservoir 110 into the external receptacle 160. The vacuum source 170 can be fluidically coupled to the external receptacle 160 via a vacuum line 124 such that gaseous fluid is drawn from the external receptacle 160 via the vacuum line 124. As a result of the decrease in pressure within the external receptacle 160 caused by the drawing of gaseous fluid out of the external receptacle 160, liquid and/or gaseous fluid can be drawn from the reservoir 110, through the outlet 120, through the discharge line 122, and into the external receptacle 160. In some implementations, the vacuum source 170 can apply sufficient suction to capture all or substantially all of the urine voided by a user in a variety of positions (e.g., when a female user is lying on her side).
The vacuum source 170 can have a sufficiently high vacuum strength and air volume transport rate such that rapid air and liquid aspiration is maintained over a portion of or the entire permeable membrane 130. In some implementations, the one or more openings of the permeable support 140 are distributed over an area that is slightly larger than the area of the permeable membrane 130 that is configured to be wetted by urine flow in operation. Thus, the partial vacuum created by the vacuum source 170 in combination with the one or more openings of the permeable support 140 and the permeable membrane 130 can draw the urine contacting the permeable membrane 130 into the assembly 102. In some implementations, however, the one or more openings of the permeable support 140 should not be distributed over too large of an area of the permeable support 140 because the partial vacuum strength may be reduced, thereby reducing the urine collection rate and the efficiency of the system 100.
In some implementations, the vacuum source 170 can be a pump that is readily available, inexpensive, relatively quiet, and/or configured to run continuously. For example, the vacuum source 170 can be an aquarium aerator pump. The vacuum line 124 can be attached to the intake port of the aquarium aerator pump (rather than the exhaust port of the aerator) such that gaseous fluid is drawn into the aquarium aerator pump from the external receptacle 160 via the vacuum line 124. In some implementations, the necessary static vacuum of the system 100 is about 3-10 feet of water (10%-30% of one atmosphere; 80-250 mm Hg) with a free-flow rate of about 10-100 cubic centimeters per second. In some implementations, the necessary static vacuum of the system 100 is higher or lower depending on the size of the user and the expected rate of urine flow from the user and/or through the system 100. In some implementations, the discharge line 122 can be about 0.25″ in diameter and the vacuum source 170 can be configured to cause about 500 cubic centimeters of urine to flow through the discharge line 122 to the external receptacle 160 over the duration of a typical urination event for a user, which may typically range from 10 to 20 seconds but may be shorter or longer, e.g., 5 to 90 seconds. In some implementations, the vacuum source 170 can include a wall-mounted vacuum system, such as is found in hospitals. In some implementations, a wall-mounted vacuum system can be configured to apply a vacuum of, for example, about 20 mm Hg to about 40 mm Hg. In some implementations, the vacuum source 170 can be powered by electrical AC or DC power. For example, in mobile applications when the user is away from an AC power source, such as when the user is using the system 100 during transportation via a wheel chair or motor vehicle, the vacuum source 170 can be powered by DC power.
The impermeable layer 150 can be impermeable to fluid, such as, for example, urine. In some implementations, the impermeable layer 150 can have a fluid transportation function and can assist in directing fluid towards the reservoir 110 and/or through the outlet 120 of the reservoir 110. In some implementations, the impermeable layer 150 can be formed as an integral, unitary structure. In other implementations, the impermeable layer 150 can be a multi-piece structure. The impermeable layer 150 can be a pre-molded (e.g., injection or blow molded) component. Alternatively, the impermeable layer 150 can be formed of a material, such as elongate strips of an adhesive tape, wrapped around at least a portion of the reservoir, a portion of the permeable support 140, and/or a portion of the permeable membrane 130. In some implementations, the impermeable layer 150 can be formed of cardboard, pressed paper, and/or coated paper.
In some implementations, as shown in
In some implementations, the permeable support 140 can optionally include a spine 148. The spine 148 can divide an inner volume of the permeable support 140 into two or more longitudinal chambers and can strengthen the permeable support 140 such that the permeable support 140 maintains an intended shape. The two chambers can be aligned with an inlet of the permeable support 140 (i.e., the one or more openings in the permeable support 140) such that fluid can flow through the inlet, through at least one of the two chambers, and into the reservoir 110. Although only one spine 148 is described, in some implementations, the permeable support 140 can include additional spines such that the permeable support 140 is divided into additional chambers.
In some implementations, the permeable support 140 can optionally include a tunnel 146. The tunnel 146 can be coupled to the outlet 120 of the assembly 102 in a configuration in which the outlet 120 is positioned on the top of the assembly 102. In some implementations, an external tube can be inserted through the tunnel 146 into contact with fluid in the reservoir 110 such that the fluid in the reservoir 110 can be removed from the assembly 102 via the external tube (e.g., using a vacuum source such as vacuum source 170). In some implementations, a length of tubing, such as the discharge line 122, can be fluidically coupled to an end of the tunnel 146 such that fluid can be drawn up the tunnel 146 from the reservoir 110 and out of the assembly 102.
In some implementations, the impermeable layer 150 can include an extension portion 156. The extension portion 156 can extend away from the permeable membrane 130 and/or the permeable support 140 such that the extension portion 156 can be gripped by a user or caregiver without contacting the permeable membrane 130. Thus, the extension portion 156 can be used to remove the permeable membrane 130 and the impermeable layer 150 from the permeable support 140. In some implementations, the extension portion 156 can be shaped as an elongated tab that extends along the length of the assembly 102 on one or more sides of the assembly 102. In some implementations, the extension portion 156 can be configured to prevent urine from traveling beyond the border between the permeable membrane 130 and the impermeable layer 150. For example, the extension portion 156 can be shaped and disposed relative to the permeable membrane 130 such that in a condition where the rate of urine flowing from the urethral opening exceeds the rate the permeable membrane 130 or a portion of the permeable membrane 130 can wick fluid and/or the rate that fluid can travel through the permeable membrane 130 and permeable support 140, the extension portion 156 can prevent urine from flowing onto an outer surface of the impermeable layer 150 beyond the extension portion 156 and can redirect urine along the permeable membrane 130 such that the urine is directed through the permeable membrane 130.
In some implementations, the impermeable layer 150 can include a stabilizer 154. The stabilizer 154 can be configured to stabilize the assembly 102 relative to a user's body. For example, in some situations of use, such as for incontinence, for disability that limits or impairs mobility, for restricted travel conditions (e.g., conditions experienced by pilots, drivers, and/or workers in hazardous areas), for monitoring purposes, or for clinical testing, it may aid the engagement between the permeable membrane 130 and the user's urethral opening and/or the area surrounding the urethral opening to include the stabilizer 154. The stabilizer 154 can be coupled to or integrally formed with the impermeable layer 150. In some implementations, a first end of the stabilizer 154 is coupled to the impermeable layer 150 and a second end of the stabilizer 154 is coupled to a user's body (e.g., via adhesive or tape) or an apparatus occupied by the user (e.g., a bed or wheelchair) to stabilize the position of the assembly 102 relative to a user's urethral opening and/or the area surrounding the urethral opening. The stabilizer 154 can be a thin, pliable strip of material. For example, in some implementations the stabilizer 154 can include tape, gauze, cotton, cloth, or plastic. The stabilizer 154 can be any suitable length and/or width. In some implementations, the stabilizer 154 can be as thin as a single thread.
In some implementations, the impermeable layer 150 can define one or more vacuum relief openings 158. Thus, in the event that a user's body envelopes the assembly 102, the one or more vacuum relief openings 158 can prevent suction from increasing against the skin of the user, which may be uncomfortable or painful. Said another way, the one or more vacuum relief openings 158 can be located between two ends of the impermeable layer 150 such that at least one additional airflow path exists in the assembly 102. The one or more vacuum relief openings 158 can be disposed at any suitable location on the impermeable layer 150. For example, in some implementations, the one or more vacuum relief openings 158 can be disposed near the outlet 120 of the apparatus 102. In some implementations, the one or more vacuum relief openings 158 can be disposed in a location that reduces the likelihood that the skin of the labia or the thigh of the user inadvertently covers the hole, such as a location near the outlet 120.
In some implementations, urine collected by any of the systems and/or assemblies described herein can be sampled for analysis using urine strips. Urine test strips can be used to test a variety of health measures. Urine test strips can be configured to change color in response to being wetted with urine to indicate a particular measurement (i.e., the colors can correspond to known measurement scales). In some implementations, a urine test strip 162 can be inserted into the discharge line 122 such that urine flowing from the outlet 120 to the external receptacle 160 contacts the urine test strip 162. The discharge line 122 can be transparent such that data on the urine test strip 162 can be read through a wall of the discharge line 122. In some implementations, the urine test strip 162 can be disposed within the external receptacle 160 such that urine flowing into the external receptacle 160 contacts the urine test strip 162. The external receptacle 160 can be at least partially transparent such that the urine test strip 162 can be read through a wall of the external receptacle 160.
As an example,
In some implementations, a camera, such as a camera built into a portable communication device (e.g., a smartphone, an iPhone, or the like) can be used to read the data on the urine test strip 162. The camera can capture an image of the test strip and the image can be processed using, for example, a smartphone application. The data read from the urine test strip can be sent to a clinician for analysis and/or sent to a cloud-based address for physician access.
In some implementations, the system 100 can include a scale 164. For example, the scale 164 can be disposed underneath the external receptacle 160 such that the scale is configured to measure the weight of fluid (e.g., urine) in the external receptacle 160. The data indicating the weight of the fluid that has been delivered to the external receptacle 160 via the discharge line 122 can be measured at different time intervals and processed to determine how much urine, for example, has been voided by a user of the system 100.
Although described as being intended for use by an adult female, in some implementations the system 100 can be used in adult, pediatric, male, female, and veterinary applications for animals of different species and sizes. In female applications, the assembly 102 can be placed between the legs or labia of the user and held snugly against the external urethra by the pressure of friction from the user's body, by the pressure of the legs or by such means as an undergarment, elastic strips, and/or adhesive tape. In male applications, the assembly 102 can be secured around the penis.
The permeable support 240 can include one or more membrane supports 244. The membrane supports 244 can be formed as struts that extend across the inlet 242. Said another way, the membrane supports 244 can divide the inlet 242 into an array of distinct slot-shaped openings (or an array of slot-shaped openings can define the membrane supports). The membrane supports 244 can be used to support a permeable membrane (e.g., permeable membrane 230 shown in
The permeable support 240 and the reservoir 210 can be formed of any suitable material. In some implementations, the permeable support 140 can be flexible. In some implementations, the permeable support 140 can be rigid. In some implementations, the permeable support 240 can be made of plastic, aluminum, a composite of plastic and aluminum, some other metal and/or a composite of plastic and another metal. Additionally, although not shown in
The assembly 202 can include a permeable membrane 230.
The permeable membrane 230 can be formed of a material that is urine permeable and has wicking properties. The permeable membrane 230 can have a high absorptive rate and a high permeation rate such that urine can be rapidly wicked by the permeable membrane 230 and/or transported through the permeable membrane 230. In some implementations, the permeable membrane 230 can be a ribbed knit fabric. In some implementations, the permeable membrane 230 can include and/or have the moisture-wicking characteristic of gauze, felt, terrycloth, thick tissue paper, and/or a paper towel. In some implementations, the permeable membrane 230 can be soft and/or minimally abrasive such that the permeable membrane 230 does not irritate the skin of the user. The permeable membrane 230 can be configured to wick fluid away from the urethral opening and/or the skin of the user such that the dampness of the skin of the user is lessened and infections are prevented. Additionally, the wicking properties of the permeable membrane 230 can help prevent urine from leaking or flowing beyond the assembly onto, for example, a bed. In some implementations, the permeable membrane 130 can be formed of fine denier polyester fibers coated with a thermoplastic water-based binder system. The tensile with the Webb direction can be, for example, about 45 lbs/inch2 measured using an Instron test method. The weight per permeable membrane can be, for example, about 12 grams measured using the Mettle Gram Scale. The thickness per ten permeable membrane can be, for example, about 2.5″, measured using the Gustin-Bacon/Measure-Matic.
In some implementations, the permeable membrane 230 can be formed as a sock or sleeve that can be slid over the permeable support 240. In some implementations, the permeable membrane 230 can be formed as a sheet that can be wrapped partially or completely around the permeable support 240. The permeable membrane 230 can be secured in place with one or more securing elements 252. In some implementations, the securing elements 252 can be impermeable and form a portion of or all of an impermeable layer (similar to impermeable layer 150 with reference to assembly 100 of
In use, the system 200 can be positioned such that the assembly 202 is abutting and/or near the urethral opening of the user. In particular, the assembly 202 can be positioned such that the inlet 242 and membrane supports 244 are facing the urethral opening such that urine exiting the urethral opening can travel through the permeable membrane 230, through the inlet 242, through the interior volume defined by the permeable support 240 and the reservoir 210, and through the outlet 220. The assembly 202 can be arranged relative to the urethral opening of the user such that gravity causes or assists urine entering the permeable support 240 in traveling to the reservoir 210. Similarly as described above with reference to system 100, the vacuum source 270 can assist and/or provide the pressure differential needed to draw fluid voided from the urethral opening into the inner volume of the assembly 202, and then from the reservoir 210 into the external receptacle 260. The vacuum source 270 can have a sufficiently high vacuum strength and air volume transport rate such that rapid air and liquid aspiration is maintained over a portion of or the entire permeable membrane 230. Additionally, the inlet 242 can be sized and shaped such that the inlet 242 is larger than the area of the permeable membrane 230 that is configured to be wetted by urine flow in operation. Thus, the partial vacuum created by the vacuum source 270 in combination with the inlet 242 and the permeable membrane 230 can draw the urine contacting the permeable membrane 230 into the assembly 202. In some implementations, however, the inlet 242 should not be distributed over too large of an area of the permeable support 240 because the partial vacuum strength may be reduced, thereby reducing the urine collection rate and the efficiency of the system 200. The vacuum source 270 can be fluidically coupled to the external receptacle 260 via a vacuum line 224 such that gaseous fluid is drawn from the external receptacle 260 via the vacuum line 224. As a result of the decrease in pressure within the external receptacle 260 caused by the drawing of gaseous fluid out of the external receptacle 260, liquid and/or gaseous fluid can be drawn from the reservoir 210, through the outlet 220, through the discharge line 222, and into the external receptacle 260.
As shown in
In use, the system 300 can be positioned such that the assembly 302 is abutting and/or near the urethral opening of the user. In particular, the assembly 302 can be positioned such that one or more openings in the permeable support (not shown) of the assembly 302 face the urethral opening such that urine exiting the urethral opening can travel through a permeable membrane of the permeable support, through the one or more openings, through an interior volume defined by the permeable support and a reservoir of the assembly 302, and through an outlet of the assembly 302 into the discharge line 322. The assembly 302 can be arranged relative to the urethral opening of the user such that gravity causes urine entering the permeable support to travel to the reservoir. Similarly as described above with reference to system 100 and/or system 200, the vacuum source 370 can assist and/or provide the pressure differential needed to draw fluid (e.g., urine) voided from the urethral opening into the inner volume of the assembly 302, and then from the reservoir, through the discharge line 322, and into the external receptacle 360. The vacuum source 370 can have a sufficiently high vacuum strength and air volume transport rate such that rapid air and liquid aspiration is maintained over a portion of or the entire permeable membrane. The vacuum source 370 can be fluidically coupled to the external receptacle 360 via the vacuum intake pipe 376 such that gaseous fluid is drawn from the external receptacle 360 via the vacuum intake pipe 376. The gaseous fluid can then be released from the system 300 via a vacuum line 324. As a result of the decrease in pressure within the external receptacle 360 caused by the drawing of gaseous fluid out of the external receptacle 360, liquid and/or gaseous fluid can be drawn from the assembly 302, through the discharge line 322, and into the external receptacle 360.
In some implementations, rather than the permeable support and the reservoir being combined as a unitary or integral structure and shaped as a cylinder of constant diameter (e.g., permeable support 240 and reservoir 210 of
As shown in
As shown in
Rather than including an outlet extending from a side of the reservoir 710, the outlet 720 of the reservoir 710 can be formed as an elongated tube positioned within the reservoir 710 and extending through a portion of the reservoir 710, through the permeable support 740, and out a top end of the permeable support 740. Thus, fluid can flow (e.g., via suction applied to the outlet 720) from the interior volume, through the outlet 720, and out the top of the apparatus 702.
In some implementations, the assembly 802 can include a permeable membrane (not shown) that includes a spray-on fabric, such as the spray-on fabric developed by Fabrican, Ltd. of London, England. The spray-on fabric can be applied to the exterior of the permeable support 840 and/or the reservoir 810. The spray-on fabric can include a liquid suspension and can be applied via, for example, a spray gun or an aerosol can. The spray-on fabric can be formed by the cross-linking of fibers which adhere to the exterior of the permeable support 840 such that the spray-on fabric forms an instant non-woven fabric when applied to the exterior of the permeable support 840 and/or the reservoir 810.
In some implementations, the assembly 802 can include a permeable membrane (not shown) similar in structure and function to any of the permeable membranes described above (such as, for example, permeable membrane 230) can be secured to the permeable support 840 and/or the reservoir 810. In some implementations, such as is shown in
The impermeable layer 850 can include one or more extension portions 856. The one or more extension portions 856 can extend away from the permeable membrane 830 and/or the permeable support 840 such that the one or more extension portions 856 can be gripped by a user or caregiver without contacting the permeable membrane 830. Thus, the one or more extension portions 856 can be used to remove the permeable membrane 830 and the impermeable layer 850 from the permeable support 840. In some implementations, the one or more extension portions 856 can be shaped as an elongated tab that extends along the length of the assembly 802 on one or more sides of the assembly 802. Although not shown, in some implementations, the permeable membrane 830 and/or the impermeable layer 850 can include a handle (not shown). The handle can be shaped as a hoop and disposed on one end of the permeable membrane 830 and/or the impermeable layer 850 to assist in positioning and removing the permeable membrane 830 and/or the impermeable layer 850 from the permeable support 840 and/or the reservoir 810.
In some implementations, the permeable membrane 830 can be formed as a sheath with a closed end such that the permeable membrane 830 can be pulled over the permeable support 840 and the reservoir 810 like a sock. For example, the permeable membrane 830 can be heat sealed on one end. In such implementations, the impermeable layer 850 can be secured to a portion of the side and/or bottom of the permeable membrane 830. In other implementations, the permeable membrane 830 can be formed as a sheath with two open ends that can be pulled over the permeable support 840 and the reservoir 810. In such implementations, the end of the permeable membrane 830 near the reservoir 810 can be left uncovered, and the impermeable layer 850 can be secured to a portion of the side and/or the bottom of the permeable membrane 830. In some implementations, the permeable membrane 830 can be a piece of material smaller than the external surface area of the permeable support 840. The permeable membrane 830 can be heat sealed to the impermeable layer 850 such that the combination of the permeable membrane 830 and the impermeable layer 850 form a sheath that can be secured to permeable support 840 and/or the reservoir 810 via, for example, pulling over the permeable support 840 and/or the reservoir 810 like a sock.
In some implementations, the assemblies described herein can include internal structures to direct fluid flow and/or provide structural support. Additionally, in some implementations, the assemblies described herein can include a first end cap and a second end cap. For example, the assemblies described herein can include the features shown and described with respect to
In an assembled configuration in which the first end cap 945 is coupled to the first end 943A of the permeable support 940 and the second end cap 947 is coupled to the second end 943B of the permeable support 940, the second end cap 947 and/or the permeable support 940 can define a reservoir 910 for collection of fluid (e.g., urine). The third flange 949C of the first end cap 945 can define an outlet for fluid collected within the reservoir 910. In some implementations, an external tube can be inserted through the first end cap 945 via the opening 941D defined by the third flange 949C and through the third channel 941C defined by the tunnel 946 until an end of the external tube reaches fluid in the reservoir defined by the second end cap 947 and/or the permeable support 940. The external tube can then be used to remove the fluid via suction. In some implementations, an external tube can be coupled to the first end cap 945, rather than extended through the first end cap 945 and into the permeable support 940. In such embodiments, suction can be applied via the external tube such that fluid (e.g., urine) in the reservoir 910 can be transported via suction through the first channel 941C and out of the opening 941D. Although not shown, in some implementations, the second flange 949C of the first end cap 945 can extend from both sides of the first end cap 945 such that the second flange 949C can form a male fitting for an external tube such that the external tube can be coupled to the second flange 949C.
In some implementations, the tunnel 946 can be formed such that a gap exists between the end of the tunnel 946 and the face of the second end cap 947 such that the tunnel 946 does not prevent fluid from flowing from the second channel 941A and/or the third channel 941B into the first channel 941C. In some implementations, the tunnel 946 is formed such that the gap between the tunnel 946 and the face of the second cap 947 is small such that a large amount of fluid does not accumulate in the reservoir 910 before reaching a height capable of being suctioned via the tunnel 946.
In some implementations, the first end cap 945 and/or the second end cap 947 can be rigid. The first end cap 945 and/or the second end cap 947 can be, for example, injection molded and formed of plastic, such as ABS or nylon. In some implementations, the first end cap 945 and/or the second end cap 947 can be flexible. In some implementations, the first end cap 945 and/or the second end cap 947 can be made of any suitable material using any suitable process.
In some implementations, the permeable support 940 can be formed of a soft material, such as, for example, polyurethane, polyethylene, or synthetic rubber. The permeable support 940 can be formed via an extrusion process. In some implementations, the material used to form the permeable support 940 can be coiled during the extrusion process such that the permeable support 940 has a curved shape to improve the fit of the permeable support 940 and/or a permeable membrane coupled to the permeable support 940 with a user's urethral opening and/or the region of a user's body surround the urethral opening. In some implementations, the permeable support 940 can be formed via injection molding. In some implementations, the permeable support 940 can be rigid or flexible, and can be formed of any suitable material or combination of materials.
In some implementations, a stabilizer can be used to maintain any of the assemblies described herein in a particular position relative to a user's body. For example,
In some implementations, the permeable membrane can include a web of flexible porous material. For example, as shown in
As shown in
In some implementations, a web of flexible porous material can be in the form of a flexible sheet rolled or folded into a tubular shape. For example, as shown in
As shown in
The assembly 1402 can include an impermeable layer 1450. As shown in
The assembly 1402 can also include a permeable membrane 1430. As shown in
In some implementations, the reservoir, the impermeable layer, and/or a portion of the outlet can be formed as an integral, one piece structure. For example,
In some implementations, the impermeable casing 1504 can be configured to contain a permeable membrane disposed over a permeable support. For example,
The permeable support 1540 in combination with the permeable membrane 1530 can be disposed within the interior of the impermeable casing 1504 such that the permeable support 1540 can maintain the permeable membrane 1530 against or near a source of moisture (e.g., a urethral opening) through the elongated opening 1504A. The permeable membrane 1530 and the permeable support 1540 can be positioned within the impermeable casing 1504 using any suitable method. For example, in some implementations, the permeable membrane 1530 can be pulled over or wrapped around the permeable support 1540. The combination of the permeable membrane 1530 and the permeable support 1540 can then be inserted through the elongated opening 1504A of the impermeable casing 1504 and the impermeable casing 1504 can be stretched and/or otherwise maneuvered such that the impermeable casing 1504 surrounds the permeable membrane 1530 except in the area of the elongated opening 1504A.
In some implementations, the permeable membrane 1530 (e.g., a tubular gauze) can first be disposed over a hollow plastic pipe (not shown). The pipe covered with the permeable membrane 1530 can be inserted through the opening 1520 of the impermeable casing 1504 such that the permeable membrane 1530 is positioned within the impermeable casing 1504. The permeable support 1540 can then be formed into a configuration such that the permeable support 1540 can function as a hollow framework for the permeable membrane 1530 (e.g., a tubular or cylindrical shape as shown in
In some implementations, the permeable membrane 1530 (e.g., a tubular gauze) can first be disposed over a hollow plastic pipe (not shown). The permeable support 1540 can then be formed into a configuration such that the permeable support 1540 can function as a hollow framework for the permeable membrane 1530 (e.g., a tubular or cylindrical shape as shown in
In some implementations, the permeable membrane 1530 can be attached to the permeable support 1540 via an adhesive or adhesive tape. In some implementations, the permeable membrane 1530 can be attached to the permeable support 1540 via compression from the impermeable casing 1504. For example, the permeable membrane 1530 can be wrapped around the permeable support 1540 and inserted into the impermeable casing 1504 such that the impermeable casing 1504 applies compression to the permeable membrane 1530 and the permeable support 1540 such that the permeable membrane 1530 and the permeable support 1540 each maintain their shape and attachment to each other. In some implementations, the permeable membrane 1530 can be secured to the permeable support 1540 by compression as a result of the permeable membrane 1530 having elastic properties. For example, the permeable membrane 1530 can include tubular compression gauze that can be applied to the permeable support 1540 as a sleeve.
The assembly 1602 can have any suitable dimension such that the assembly 1602 can be configured to engage with the urethral opening and/or the area surrounding the urethral opening of users of different sizes and/or anatomical structures. For example, in some embodiments, the impermeable casing 1604 can range from about 7 inches to about 8 inches in length (i.e. from a tip of the reservoir 1610 to the opening in the outlet 1620). In some embodiments, such as for larger patients, the impermeable casing 1604 can range from about 9 inches to about 10 inches in length. In some embodiments, such as for smaller adult patients or children, the impermeable casing 1604 can range from about 3 inches to about 5 inches in length. In some embodiments, the impermeable casing 1604 can range from about 3 inches to about 10 inches in length. The elongated opening 1604A can range from about 5 inches to about 6 inches in length. In some embodiments, the diameter of the impermeable casing 1604 can be about 1 inch. In some embodiments, the diameter of the impermeable casing 1604 can range from about 0.5 inches to about 1.5 inches in diameter. The elongated opening 1604A can have a width of about 1 inch and a depth of about 0.5 inches relative to the height (i.e. diameter) of the impermeable casing 1604. The permeable support 1640 can have a diameter of about 0.875 inches. The outlet 1620 can be about 0.25 inches long and about 0.5 inches wide. The opening of the outlet 1620 can have a diameter of about 0.375 inches. Additionally, the tube 1621 can have a diameter of about 0.375 inches.
Additionally, the assembly 1602 can include any suitable curve such that the assembly 1602 can engage with a user's urethral opening and/or area surrounding the urethral opening. For example, in some embodiments, the assembly 1602 and/or the impermeable casing 1604 can have an angle of curvature of about 40°. In some embodiments, the assembly 1602 and/or the impermeable casing 1604 can have an angle of curvature of about 60°. In some embodiments, the assembly 1602 and/or the impermeable casing 1604 can have a radius of curvature ranging from about 6 inches to about 10 inches.
In some embodiments, the permeable membrane 1630 and/or the permeable support 1640 can be disposed fully within the impermeable casing 1604 such that the permeable membrane 1630 and/or the permeable support 1640 does not extend through the elongated opening 1604A. In some embodiments, the permeable membrane 1630 and/or the permeable support 1640 can be disposed within the impermeable casing 1604 such that a portion of the permeable membrane 1630 and/or a portion of the permeable support 1640 extends through the elongated opening 1604A.
As shown in
In some implementations, an impermeable layer can define one or more vacuum relief openings. For example,
In some implementations, rather than including an impermeable casing, an assembly can include an impermeable backing that includes adhesive tape. For example,
As shown in
As shown in
The method 1900 also includes, at 1908, allowing urine discharged from the urethral opening to be received through the opening of the fluid impermeable layer, the membrane, the support, and into the reservoir.
The method 1900 also includes, at 1910, allowing the received urine to be withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
The method 1900 optionally includes, at 1912, removing the urine collecting apparatus from the operative relationship with the urethral opening of the user.
Finally, the method 1900 optionally includes, at 1914, disposing a second urine collecting apparatus in operative relationship with the urethral opening of the user.
In some embodiments, the support and casing can be cylindrical and can have a curved shape with the elongated opening disposed on the inside of the curve. The disposing can include disposing the urine collecting apparatus with the elongated opening adjacent the urethral opening of the user and oriented with the reservoir proximal to the user's anus and the outlet disposed above the urethral opening.
In some embodiments, an assembly (such as, for example, the assembly 1602 shown in
In some implementations, the tube 2121 can be initially formed such that it has an uncurved (i.e., straight) overall shape. The tube 2121 can then be curved via, for example, heat setting. Said another way, the tube 2121 can be formed of a stiff or rigid material, such as a stiff plastic, in a straight shape. The tube 2121 can be heated such that the tube 2121 is softened, and then the tube 2121 can be bent to a predefined curved shape. After being curved, the tube 2121 can be cooled such that the tube 2121 hardens.
In some implementations, the tube 2121 can be precurved by initially forming the tube 2121 such that the tube 2121 has a straight shape and then bending the tube 2121 beyond the elastic limit of the tube 2121 such that the tube 2121 has a preset curve. For example, the tube 2121 can be formed of a material such as metal that will retain a curved shape after being bent to the curved shape.
In some embodiments, an assembly (such as, for example, the assembly 1602 shown in
In some embodiments, a tube with an intake end positioned within a reservoir such that the tube extends from the reservoir and through at least a portion of a permeable support, similar to, for example, the tube 1621 shown with respect to
In some embodiments, an assembly can include a casing that includes a channel defined in a sidewall of the casing, instead of the tube extending within the casing, as disclosed in many of the previous embodiments. For example,
The channel 2490 can extend along the length of the casing 2404, as shown, from the opening 2480 to an outlet 2420 such that fluid in the reservoir 2410 can be removed via the opening 2480 through the channel 2490 via, for example, a vacuum source (not shown) coupled to the outlet 2420. Although shown as having a crescent shape, the channel 2490 can be formed in any suitable shape. For example, the channel 2490 can be tubular. In some implementations, as shown in
The casing 2404 can be made from material similar in structure and/or function to any of the casings described herein, such as, for example, the casing 1504 shown in
In some embodiments, rather than the channel being collectively defined by an external wall and an impermeable backing, the assembly can include an external tube defining a channel. For example,
In some implementations, the assembly 2500 can include an external tube 2522 defining a channel. The outlet tube 2528 can be coupled to the external tube 2522 such that the channel of the external tube 2522 is in fluidic communication with the lumen of the outlet tube 2528 (and, thus, the reservoir 2510). The outlet tube 2528 can have any suitable length for fluidically coupling the reservoir 2510 with the external tube 2522. The outlet tube 2528 can be secured to the external tube 2522 using any suitable coupling mechanism such as, for example, a leak-proof tube connecting apparatus, adhesive, and/or tape. In some implementations, the external tube 2522 can be fluidically coupled to a vacuum source (not shown) such that fluid can be evacuated from the reservoir 2510 via suction created by the vacuum source. The outlet tube 2528 (and the casing 2504 if formed integrally with tube 2528) can be made from material similar in structure and/or function to any of the casings described herein, such as, for example, the casing 2404 shown in
In some embodiments, rather than including a permeable membrane disposed on a permeable support, the permeable support can be formed of a material that provides the functions of both the permeable membrane and the permeable support. For example,
As noted above, the permeable support 2640 can be the same or similar in function to the permeable membranes and/or the permeable supports, respectively, described in the previous embodiments. The permeable support 2640, however, can be formed of a single material that meets the functional requirements and/or includes the functional benefits of the materials of both the permeable membranes and the permeable supports of the previous embodiments. Specifically, the material of which permeable support 2640 is formed can have sufficient structural integrity to serve as a permeable support for the casing 2604, sufficient porosity and/or permeability to allow urine to pass freely through the permeable support 2640, and/or sufficient loft and resiliency to extend to or out of the elongated opening 2604A. The permeable support 2640 can also be sufficiently pliable and/or flexible such that the assembly 2602 can conform to differently shaped and/or sized users to ensure effective and secure placement of the assembly 2602.
In addition, the material of which the permeable support 2640 is formed can have an exterior surface that provides the same functions as the permeable membranes of the previous embodiments. Thus, the permeable support 2640 can be urine permeable and can have wicking properties. Specifically, the permeable support 2640 can have a high absorptive rate and a high permeation rate such that urine can be rapidly absorbed and/or transported therethrough. The permeable support 2640 can be soft and/or minimally abrasive such that it does not irritate the skin of the user. Additionally, the permeable support 2640 can wick fluid away from the urethral opening and/or the skin of the user such that the dampness of the skin of the user is lessened and infections are prevented. The permeable support 2640 can also be sufficiently permeable and/or have sufficient wicking ability to help prevent urine from leaking or flowing beyond the assembly onto, for example, a bed.
The material of which the permeable support 2640 is formed can be in the form of a flexible sheet rolled or folded into a tubular form, for example, as shown in
In use, once inserted and positioned against the impermeable backing 2650, the assembly 2602 may be positioned relative to a user such that the surface of the permeable support 2640 contacts the urethral opening of the user. Urine can be drawn through the permeable support 2640 such that the urine collects in the reservoir 2610. The urine can then be drawn from the reservoir 2610 via the tube 2621 and through the outlet 2620 using, for example, an external vacuum source (not shown). The material of which permeable support 2640 is formed may be compressible. The material can also have sponge-like properties such that the material can maintain shape when wet, thereby maintaining contact with the user during a urination event via a slight protrusion of the permeable support 2640 outside the casing 2604 via the elongated opening 2604A. While the permeable support 2640 is shown with casing 2604 in
In some embodiments, rather than including an outlet tube as shown and described with respect to assembly 2500 in
The assembly 2702 can include an outlet tube 2726 that can be inserted into the casing 2704 through the opening 2780 such that the inserted open end of the tube 2726 can be disposed within the reservoir 2710. In such an arrangement, a lumen of the tube 2726 can be in fluidic communication with the reservoir. An exemplary casing 2704 with a mounted outlet tube 2726 is shown in cross-sectional view in
Although
In some implementations, the two openings 2880A and 2880B can be disposed at any suitable location along the length and width of the casing 2804 such that there may be sufficient spatial separation between the reservoir ends of the first tube 2826A and the second tube 2826B for maximal and effective extraction of urine collected in the reservoir 2810 during use of the assembly 2802. Additionally, the two openings 2880A and 2880B may be positioned such that proper coupling between the first tube 2826A, the second tube 2826B, and the casing can be ensured.
The assembly 2802 can be fashioned such that the outlet tubes 2826A and 2826B extend along the outside of the casing 2804 as shown in
Although the assembly 2802 is shown to include a permeable support 2840 (indicated by the dot pattern) and a permeable membrane 2830 (indicated by a cross pattern) in
While various embodiments of the system, methods and devices have been described above, it should be understood that they have been presented by way of example only, and not limitation. Where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art having the benefit of this disclosure would recognize that the ordering of certain steps may be modified and such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. The embodiments have been particularly shown and described, but it will be understood that various changes in form and details may be made.
For example, although various embodiments have been described as having particular features and/or combinations of components, other embodiments are possible having any combination or sub-combination of any features and/or components from any of the embodiments described herein. In addition, the specific configurations of the various components can also be varied. For example, the size and specific shape of the various components can be different than the embodiments shown, while still providing the functions as described herein.
Number | Name | Date | Kind |
---|---|---|---|
670602 | Baker | Mar 1901 | A |
737443 | Mooers | Aug 1903 | A |
1032841 | Koenig | Jul 1912 | A |
1178644 | Johnson | Apr 1916 | A |
1742080 | Jones | Dec 1929 | A |
1979899 | Obrien et al. | Nov 1934 | A |
2241010 | Chipley | May 1941 | A |
2262772 | Peder | Nov 1941 | A |
2326881 | Packer | Aug 1943 | A |
2379346 | Farrell | Jun 1945 | A |
2485555 | Bester | Oct 1949 | A |
2613670 | Edward | Oct 1952 | A |
2616426 | Adele | Nov 1952 | A |
2644234 | Earl | Jul 1953 | A |
2648335 | Chambers | Aug 1953 | A |
2859786 | Tupper | Nov 1958 | A |
2944551 | Carl | Jul 1960 | A |
2968046 | Duke | Jan 1961 | A |
2971512 | Reinhardt | Feb 1961 | A |
3032038 | Swinn | May 1962 | A |
3077883 | Hill | Feb 1963 | A |
3087938 | Hans et al. | Apr 1963 | A |
3169528 | Knox et al. | Feb 1965 | A |
3171506 | Therkel | Mar 1965 | A |
3194238 | Breece | Jul 1965 | A |
3198994 | Hildebrandt et al. | Aug 1965 | A |
3221742 | Egon | Dec 1965 | A |
3312221 | Overment | Apr 1967 | A |
3312981 | Mcguire et al. | Apr 1967 | A |
3349768 | Keane | Oct 1967 | A |
3362590 | Gene | Jan 1968 | A |
3366116 | Huck | Jan 1968 | A |
3398848 | Donovan | Aug 1968 | A |
3400717 | Bruce et al. | Sep 1968 | A |
3406688 | Bruce | Oct 1968 | A |
3424163 | Gunnar | Jan 1969 | A |
3425471 | Yates | Feb 1969 | A |
3511241 | Lee | May 1970 | A |
3512185 | Ellis | May 1970 | A |
3520300 | Flower | Jul 1970 | A |
3528423 | Lee | Sep 1970 | A |
3613123 | Langstrom | Oct 1971 | A |
3648700 | Warner | Mar 1972 | A |
3651810 | Ormerod | Mar 1972 | A |
3661155 | Lindan | May 1972 | A |
3683918 | Pizzella | Aug 1972 | A |
3699815 | Holbrook | Oct 1972 | A |
3726277 | Hirschman | Apr 1973 | A |
3742952 | Magers et al. | Jul 1973 | A |
3757355 | Allen et al. | Sep 1973 | A |
3788324 | Lim | Jan 1974 | A |
3843016 | Bornhorst et al. | Oct 1974 | A |
3863638 | Rogers et al. | Feb 1975 | A |
3863798 | Kurihara et al. | Feb 1975 | A |
3864759 | Horiuchi | Feb 1975 | A |
3881486 | Fenton | May 1975 | A |
3881489 | Hartwell | May 1975 | A |
3915189 | Holbrook et al. | Oct 1975 | A |
3998228 | Poidomani | Dec 1976 | A |
3999550 | Martin | Dec 1976 | A |
4015604 | Csillag | Apr 1977 | A |
4020843 | Kanall | May 1977 | A |
4022213 | Stein | May 1977 | A |
4027776 | Douglas | Jun 1977 | A |
4064962 | Hunt | Dec 1977 | A |
4116197 | Bermingham | Sep 1978 | A |
4180178 | Turner | Dec 1979 | A |
4187953 | Turner | Feb 1980 | A |
4194508 | Anderson | Mar 1980 | A |
4200102 | Duhamel et al. | Apr 1980 | A |
4202058 | Anderson | May 1980 | A |
4203503 | Bertotti et al. | May 1980 | A |
4209076 | Bertotti et al. | Jun 1980 | A |
4233025 | Larson et al. | Nov 1980 | A |
4233978 | Hickey | Nov 1980 | A |
4246901 | Frosch et al. | Jan 1981 | A |
4253542 | Ruspa et al. | Mar 1981 | A |
4257418 | Hessner | Mar 1981 | A |
4270539 | Frosch et al. | Jun 1981 | A |
4281655 | Terauchi | Aug 1981 | A |
4292916 | Bradley et al. | Oct 1981 | A |
4330239 | Gannaway | May 1982 | A |
4352356 | Tong | Oct 1982 | A |
4360933 | Kimura | Nov 1982 | A |
4365363 | Windauer | Dec 1982 | A |
4375841 | Vielbig | Mar 1983 | A |
4387726 | Denard | Jun 1983 | A |
4425130 | Desmarais | Jan 1984 | A |
4446986 | Bowen et al. | May 1984 | A |
4453938 | Brendling | Jun 1984 | A |
4457314 | Knowles | Jul 1984 | A |
4476879 | Jackson | Oct 1984 | A |
4526688 | Schmidt et al. | Jul 1985 | A |
4528703 | Kraus | Jul 1985 | A |
D280438 | Wendt | Sep 1985 | S |
4551141 | McNeil | Nov 1985 | A |
4553968 | Komis | Nov 1985 | A |
4581026 | Schneider | Apr 1986 | A |
4589516 | Inoue et al. | May 1986 | A |
4601716 | Smith | Jul 1986 | A |
4610675 | Triunfol | Sep 1986 | A |
4620333 | Ritter | Nov 1986 | A |
4626250 | Schneider | Dec 1986 | A |
4627846 | Ternstroem | Dec 1986 | A |
4631061 | Martin | Dec 1986 | A |
4650477 | Johnson | Mar 1987 | A |
4655754 | Richmond et al. | Apr 1987 | A |
4656675 | Fajnsztajn | Apr 1987 | A |
4681570 | Dalton | Jul 1987 | A |
4681577 | Stern et al. | Jul 1987 | A |
4692160 | Nussbaumer | Sep 1987 | A |
4707864 | Ikematsu et al. | Nov 1987 | A |
4713065 | Koot | Dec 1987 | A |
4713066 | Komis | Dec 1987 | A |
4723953 | Pratt et al. | Feb 1988 | A |
4735841 | Sourdet | Apr 1988 | A |
4743236 | Manschot | May 1988 | A |
4747166 | Kuntz | May 1988 | A |
4752944 | Conrads et al. | Jun 1988 | A |
4769215 | Ehrenkranz | Sep 1988 | A |
4771484 | Mozell | Sep 1988 | A |
4772280 | Rooyakkers | Sep 1988 | A |
4790830 | Hamacher | Dec 1988 | A |
4790835 | Elias | Dec 1988 | A |
4791686 | Taniguchi et al. | Dec 1988 | A |
4795449 | Schneider et al. | Jan 1989 | A |
4798603 | Meyer et al. | Jan 1989 | A |
4799928 | Crowley | Jan 1989 | A |
4804377 | Hanifl et al. | Feb 1989 | A |
4812053 | Bhattacharjee | Mar 1989 | A |
4813943 | Smith | Mar 1989 | A |
4820297 | Kaufman et al. | Apr 1989 | A |
4846818 | Keldahl et al. | Jul 1989 | A |
4846909 | Klug et al. | Jul 1989 | A |
4865595 | Heyden | Sep 1989 | A |
4880417 | Yabrov et al. | Nov 1989 | A |
4882794 | Stewart | Nov 1989 | A |
4883465 | Brennan | Nov 1989 | A |
4886498 | Newton | Dec 1989 | A |
4886508 | Washington | Dec 1989 | A |
4886509 | Mattsson | Dec 1989 | A |
4889532 | Metz et al. | Dec 1989 | A |
4889533 | Beecher | Dec 1989 | A |
4890691 | Ching-ho | Jan 1990 | A |
4903254 | Haas | Feb 1990 | A |
4904248 | Vaillancourt | Feb 1990 | A |
4905692 | More | Mar 1990 | A |
4936838 | Cross et al. | Jun 1990 | A |
4955922 | Terauchi | Sep 1990 | A |
4957487 | Gerow | Sep 1990 | A |
4965460 | Tanaka et al. | Oct 1990 | A |
4987849 | Sherman | Jan 1991 | A |
5002541 | Conkling et al. | Mar 1991 | A |
5004463 | Nigay | Apr 1991 | A |
5031248 | Kemper | Jul 1991 | A |
5045077 | Blake | Sep 1991 | A |
5045283 | Patel | Sep 1991 | A |
5049144 | Payton | Sep 1991 | A |
5053339 | Patel | Oct 1991 | A |
5057092 | Webster | Oct 1991 | A |
5058088 | Haas et al. | Oct 1991 | A |
5071347 | Mcguire | Dec 1991 | A |
5078707 | Peter | Jan 1992 | A |
5084037 | Barnett | Jan 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5112324 | Wallace | May 1992 | A |
5147301 | Ruvio | Sep 1992 | A |
5176667 | Debring | Jan 1993 | A |
5195997 | Carns | Mar 1993 | A |
5196654 | Diflora et al. | Mar 1993 | A |
5203699 | Mcguire | Apr 1993 | A |
5244458 | Takasu | Sep 1993 | A |
5246454 | Peterson | Sep 1993 | A |
5267988 | Farkas | Dec 1993 | A |
5275307 | Freese | Jan 1994 | A |
5282795 | Finney | Feb 1994 | A |
5294983 | Ersoz et al. | Mar 1994 | A |
5295983 | Kubo | Mar 1994 | A |
5300052 | Kubo | Apr 1994 | A |
5304749 | Crandell | Apr 1994 | A |
5312383 | Kubalak | May 1994 | A |
5318550 | Cermak et al. | Jun 1994 | A |
5330459 | Lavon et al. | Jul 1994 | A |
5340840 | Park et al. | Aug 1994 | A |
5382244 | Telang | Jan 1995 | A |
5409014 | Napoli et al. | Apr 1995 | A |
5411495 | Willingham | May 1995 | A |
5423784 | Metz | Jun 1995 | A |
5456246 | Schmieding et al. | Oct 1995 | A |
5466229 | Elson et al. | Nov 1995 | A |
5478334 | Bernstein | Dec 1995 | A |
5499977 | Marx | Mar 1996 | A |
5543042 | Filan et al. | Aug 1996 | A |
D373928 | Green | Sep 1996 | S |
5582604 | Ahr et al. | Dec 1996 | A |
5592950 | Kopelowicz | Jan 1997 | A |
5605161 | Cross | Feb 1997 | A |
5618277 | Goulter | Apr 1997 | A |
5628735 | Skow | May 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5637104 | Ball et al. | Jun 1997 | A |
5674212 | Osborn et al. | Oct 1997 | A |
5678564 | Lawrence et al. | Oct 1997 | A |
5678654 | Uzawa | Oct 1997 | A |
5687429 | Rahlff | Nov 1997 | A |
5695485 | Duperret et al. | Dec 1997 | A |
5700254 | Mcdowall et al. | Dec 1997 | A |
5701612 | Daneshvar | Dec 1997 | A |
5705777 | Flanigan et al. | Jan 1998 | A |
5752944 | Dann et al. | May 1998 | A |
5772644 | Bark et al. | Jun 1998 | A |
5792132 | Garcia | Aug 1998 | A |
5827243 | Palestrant | Oct 1998 | A |
5827247 | Kay | Oct 1998 | A |
5827250 | Fujioka et al. | Oct 1998 | A |
5827257 | Fujioka et al. | Oct 1998 | A |
D401699 | Herchenbach et al. | Nov 1998 | S |
5859393 | Cummins et al. | Jan 1999 | A |
5865378 | Hollinshead et al. | Feb 1999 | A |
5876393 | Ahr et al. | Mar 1999 | A |
5887291 | Bellizzi | Mar 1999 | A |
5891125 | Plumley | Apr 1999 | A |
5894608 | Birbara | Apr 1999 | A |
D409303 | Oepping | May 1999 | S |
5911222 | Lawrence et al. | Jun 1999 | A |
5957904 | Holland | Sep 1999 | A |
5968026 | Osborn et al. | Oct 1999 | A |
5972505 | Phillips et al. | Oct 1999 | A |
6039060 | Rower | Mar 2000 | A |
6050983 | Moore et al. | Apr 2000 | A |
6059762 | Boyer et al. | May 2000 | A |
6063064 | Tuckey et al. | May 2000 | A |
6098625 | Winkler | Aug 2000 | A |
6105174 | Karlsten et al. | Aug 2000 | A |
6113582 | Dwork | Sep 2000 | A |
6117163 | Bierman | Sep 2000 | A |
6123398 | Arai et al. | Sep 2000 | A |
6129718 | Wada et al. | Oct 2000 | A |
6131964 | Sareshwala | Oct 2000 | A |
6152902 | Christian et al. | Nov 2000 | A |
6164569 | Hollinshead et al. | Dec 2000 | A |
6177606 | Etheredge et al. | Jan 2001 | B1 |
6209142 | Mattsson et al. | Apr 2001 | B1 |
6220050 | Cooksey | Apr 2001 | B1 |
6244311 | Hand et al. | Jun 2001 | B1 |
6248096 | Dwork et al. | Jun 2001 | B1 |
6263887 | Dunn | Jul 2001 | B1 |
6283246 | Nishikawa | Sep 2001 | B1 |
6311339 | Kraus | Nov 2001 | B1 |
6336919 | Davis et al. | Jan 2002 | B1 |
6338729 | Wada et al. | Jan 2002 | B1 |
6352525 | Wakabayashi | Mar 2002 | B1 |
6394988 | Hashimoto | May 2002 | B1 |
6398742 | Kim | Jun 2002 | B1 |
6406463 | Brown | Jun 2002 | B1 |
6409712 | Dutari et al. | Jun 2002 | B1 |
6416500 | Wada et al. | Jul 2002 | B1 |
6423045 | Wise et al. | Jul 2002 | B1 |
6428521 | Droll | Aug 2002 | B1 |
6428522 | Dipalma et al. | Aug 2002 | B1 |
6446454 | Lee et al. | Sep 2002 | B1 |
6475198 | Lipman et al. | Nov 2002 | B1 |
6479726 | Cole et al. | Nov 2002 | B1 |
6491673 | Palumbo et al. | Dec 2002 | B1 |
6508794 | Palumbo et al. | Jan 2003 | B1 |
6524292 | Dipalma et al. | Feb 2003 | B1 |
6540729 | Wada et al. | Apr 2003 | B1 |
6547771 | Robertson et al. | Apr 2003 | B2 |
6569133 | Cheng et al. | May 2003 | B2 |
D476518 | Doppelt | Jul 2003 | S |
6592560 | Snyder et al. | Jul 2003 | B2 |
6610038 | Dipalma et al. | Aug 2003 | B1 |
6618868 | Minnick | Sep 2003 | B2 |
6620142 | Flueckiger | Sep 2003 | B1 |
6629651 | Male et al. | Oct 2003 | B1 |
6635038 | Scovel | Oct 2003 | B2 |
6652495 | Walker | Nov 2003 | B1 |
6666850 | Ahr et al. | Dec 2003 | B1 |
6685684 | Falconer | Feb 2004 | B1 |
6695828 | Dipalma et al. | Feb 2004 | B1 |
6700034 | Lindsay et al. | Mar 2004 | B1 |
6702793 | Sweetser et al. | Mar 2004 | B1 |
6706027 | Harvie et al. | Mar 2004 | B2 |
6732384 | Scott | May 2004 | B2 |
6736977 | Hall et al. | May 2004 | B1 |
6740066 | Wolff et al. | May 2004 | B2 |
6764477 | Chen et al. | Jul 2004 | B1 |
6783519 | Samuelsson | Aug 2004 | B2 |
6796974 | Palumbo et al. | Sep 2004 | B2 |
6814547 | Childers et al. | Nov 2004 | B2 |
6849065 | Schmidt et al. | Feb 2005 | B2 |
6857137 | Otto | Feb 2005 | B2 |
6885690 | Aggerstam et al. | Apr 2005 | B2 |
6888044 | Fell et al. | May 2005 | B2 |
6893425 | Dunn et al. | May 2005 | B2 |
6912737 | Ernest et al. | Jul 2005 | B2 |
6918899 | Harvie | Jul 2005 | B2 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
7018366 | Easter | Mar 2006 | B2 |
7066411 | Male et al. | Jun 2006 | B2 |
7122023 | Hinoki | Oct 2006 | B1 |
7125399 | Miskie | Oct 2006 | B2 |
7131964 | Harvie | Nov 2006 | B2 |
7135012 | Harvie | Nov 2006 | B2 |
7141043 | Harvie | Nov 2006 | B2 |
D533972 | La | Dec 2006 | S |
7160273 | Greter et al. | Jan 2007 | B2 |
7171699 | Ernest et al. | Feb 2007 | B2 |
7171871 | Kozak | Feb 2007 | B2 |
7179951 | Krishnaswamy-mirle et al. | Feb 2007 | B2 |
7181781 | Trabold et al. | Feb 2007 | B1 |
7186245 | Cheng et al. | Mar 2007 | B1 |
7192424 | Cooper | Mar 2007 | B2 |
7219764 | Forbes | May 2007 | B1 |
7220250 | Suzuki et al. | May 2007 | B2 |
D562975 | Otto | Feb 2008 | S |
7335189 | Harvie | Feb 2008 | B2 |
7358282 | Krueger et al. | Apr 2008 | B2 |
7390320 | Machida et al. | Jun 2008 | B2 |
7438706 | Koizumi et al. | Oct 2008 | B2 |
7488310 | Yang | Feb 2009 | B2 |
7491194 | Oliwa | Feb 2009 | B1 |
D591106 | Dominique et al. | Apr 2009 | S |
7513381 | Heng et al. | Apr 2009 | B2 |
7520872 | Biggie et al. | Apr 2009 | B2 |
D593801 | Wilson et al. | Jun 2009 | S |
7540364 | Sanderson | Jun 2009 | B2 |
7549512 | Newberry | Jun 2009 | B2 |
7585293 | Vermaak | Sep 2009 | B2 |
7588560 | Dunlop | Sep 2009 | B1 |
7665359 | Barber | Feb 2010 | B2 |
7682347 | Parks et al. | Mar 2010 | B2 |
7687004 | Allen | Mar 2010 | B2 |
7695459 | Gilbert et al. | Apr 2010 | B2 |
7695460 | Wada et al. | Apr 2010 | B2 |
7699818 | Gilbert | Apr 2010 | B2 |
7699831 | Bengtson et al. | Apr 2010 | B2 |
7722584 | Tanaka | May 2010 | B2 |
7727206 | Gorres | Jun 2010 | B2 |
7740620 | Gilbert et al. | Jun 2010 | B2 |
7749205 | Tazoe | Jul 2010 | B2 |
7755497 | Wada et al. | Jul 2010 | B2 |
7766887 | Burns et al. | Aug 2010 | B2 |
D625407 | Koizumi et al. | Oct 2010 | S |
7806879 | Brooks et al. | Oct 2010 | B2 |
7811272 | Lindsay et al. | Oct 2010 | B2 |
7815067 | Matsumoto et al. | Oct 2010 | B2 |
7833169 | Hannon | Nov 2010 | B2 |
7857806 | Karpowicz et al. | Dec 2010 | B2 |
7866942 | Harvie | Jan 2011 | B2 |
7871385 | Levinson et al. | Jan 2011 | B2 |
7875010 | Frazier et al. | Jan 2011 | B2 |
7901389 | Mombrinie | Mar 2011 | B2 |
7927320 | Goldwasser et al. | Apr 2011 | B2 |
7927321 | Marland | Apr 2011 | B2 |
7931634 | Swiecicki et al. | Apr 2011 | B2 |
7939706 | Okabe et al. | May 2011 | B2 |
7946443 | Stull et al. | May 2011 | B2 |
7947025 | Buglino et al. | May 2011 | B2 |
7963419 | Burney et al. | Jun 2011 | B2 |
7976519 | Bubb et al. | Jul 2011 | B2 |
7993318 | Olsson et al. | Aug 2011 | B2 |
8015627 | Baker et al. | Sep 2011 | B2 |
8016071 | Martinus et al. | Sep 2011 | B1 |
8028460 | Williams | Oct 2011 | B2 |
8047398 | Dimartino et al. | Nov 2011 | B2 |
8083094 | Caulfield et al. | Dec 2011 | B2 |
8128608 | Thevenin | Mar 2012 | B2 |
8181651 | Pinel | May 2012 | B2 |
8181819 | Burney et al. | May 2012 | B2 |
8211063 | Bierman et al. | Jul 2012 | B2 |
8221369 | Parks et al. | Jul 2012 | B2 |
8241262 | Mahnensmith | Aug 2012 | B2 |
8277426 | Wilcox et al. | Oct 2012 | B2 |
8287508 | Sanchez | Oct 2012 | B1 |
8303554 | Tsai et al. | Nov 2012 | B2 |
8322565 | Caulfield et al. | Dec 2012 | B2 |
8337477 | Parks et al. | Dec 2012 | B2 |
D674241 | Bickert et al. | Jan 2013 | S |
8343122 | Gorres | Jan 2013 | B2 |
8343125 | Kawazoe et al. | Jan 2013 | B2 |
8353074 | Krebs | Jan 2013 | B2 |
8353886 | Bester et al. | Jan 2013 | B2 |
D676241 | Merrill | Feb 2013 | S |
8388588 | Wada et al. | Mar 2013 | B2 |
D679807 | Burgess et al. | Apr 2013 | S |
8425482 | Khoubnazar | Apr 2013 | B2 |
8434586 | Pawelski et al. | May 2013 | B2 |
8449510 | Martini et al. | May 2013 | B2 |
D684260 | Lund et al. | Jun 2013 | S |
8470230 | Caulfield et al. | Jun 2013 | B2 |
8479941 | Matsumoto et al. | Jul 2013 | B2 |
8479949 | Henkel | Jul 2013 | B2 |
8500719 | Simpson et al. | Aug 2013 | B1 |
8512301 | Ma | Aug 2013 | B2 |
8529530 | Koch et al. | Sep 2013 | B2 |
8535284 | Joder et al. | Sep 2013 | B2 |
8546639 | Wada et al. | Oct 2013 | B2 |
8551075 | Bengtson | Oct 2013 | B2 |
8568376 | Delattre et al. | Oct 2013 | B2 |
D694404 | Burgess et al. | Nov 2013 | S |
8585683 | Bengtson et al. | Nov 2013 | B2 |
8586583 | Hamblin et al. | Nov 2013 | B2 |
8652112 | Johannison et al. | Feb 2014 | B2 |
8669412 | Fernkvist et al. | Mar 2014 | B2 |
D702973 | Norland et al. | Apr 2014 | S |
8703032 | Menon et al. | Apr 2014 | B2 |
D704330 | Cicatelli | May 2014 | S |
D704510 | Mason et al. | May 2014 | S |
D705423 | Walsh Cutler | May 2014 | S |
D705926 | Burgess et al. | May 2014 | S |
8714394 | Wulf | May 2014 | B2 |
8715267 | Bengtson et al. | May 2014 | B2 |
8757425 | Copeland | Jun 2014 | B2 |
8777032 | Biesecker et al. | Jul 2014 | B2 |
8808260 | Koch et al. | Aug 2014 | B2 |
8864730 | Conway et al. | Oct 2014 | B2 |
8881923 | Higginson | Nov 2014 | B2 |
8882731 | Suzuki et al. | Nov 2014 | B2 |
8936585 | Carson et al. | Jan 2015 | B2 |
D729581 | Boroski | May 2015 | S |
9028460 | Medeiros | May 2015 | B2 |
9056698 | Noer | Jun 2015 | B2 |
9078792 | Ruiz | Jul 2015 | B2 |
9145879 | Pirovano et al. | Sep 2015 | B2 |
9173602 | Gilbert | Nov 2015 | B2 |
9173799 | Tanimoto et al. | Nov 2015 | B2 |
9187220 | Biesecker et al. | Nov 2015 | B2 |
9199772 | Krippendorf | Dec 2015 | B2 |
9233020 | Matsumiya | Jan 2016 | B2 |
9248058 | Conway et al. | Feb 2016 | B2 |
9308118 | Dupree et al. | Apr 2016 | B1 |
9309029 | Incorvia et al. | Apr 2016 | B2 |
9333281 | Giezendanner et al. | May 2016 | B2 |
9381108 | Longoni et al. | Jul 2016 | B2 |
9382047 | Schmidtner et al. | Jul 2016 | B2 |
9402424 | Roy | Aug 2016 | B2 |
9456937 | Ellis | Oct 2016 | B2 |
9480595 | Baham et al. | Nov 2016 | B2 |
9517865 | Albers et al. | Dec 2016 | B2 |
D777941 | Piramoon | Jan 2017 | S |
9533806 | Ding et al. | Jan 2017 | B2 |
9550611 | Hodge | Jan 2017 | B2 |
9555930 | Campbell et al. | Jan 2017 | B2 |
9623159 | Locke | Apr 2017 | B2 |
D789522 | Burgess et al. | Jun 2017 | S |
9687849 | Bruno et al. | Jun 2017 | B2 |
9694949 | Hendricks et al. | Jul 2017 | B2 |
9709048 | Kinjo | Jul 2017 | B2 |
9713547 | Lee et al. | Jul 2017 | B2 |
9732754 | Huang et al. | Aug 2017 | B2 |
9752564 | Arceno et al. | Sep 2017 | B2 |
9788992 | Harvie | Oct 2017 | B2 |
D804907 | Sandoval | Dec 2017 | S |
9868564 | McGirr et al. | Jan 2018 | B2 |
D814239 | Arora | Apr 2018 | S |
D817484 | Lafond | May 2018 | S |
10037640 | Gordon | Jul 2018 | B2 |
10058470 | Phillips | Aug 2018 | B2 |
10098990 | Koch et al. | Oct 2018 | B2 |
D835264 | Mozzicato et al. | Dec 2018 | S |
D835779 | Mozzicato et al. | Dec 2018 | S |
D840533 | Mozzicato et al. | Feb 2019 | S |
D840534 | Mozzicato et al. | Feb 2019 | S |
10225376 | Perez Martinez | Mar 2019 | B2 |
10226376 | Sanchez et al. | Mar 2019 | B2 |
10258517 | Maschino et al. | Apr 2019 | B1 |
D848612 | Mozzicato et al. | May 2019 | S |
10307305 | Hodges | Jun 2019 | B1 |
10335121 | Desai | Jul 2019 | B2 |
D856512 | Cowart et al. | Aug 2019 | S |
10376406 | Newton | Aug 2019 | B2 |
10376407 | Newton | Aug 2019 | B2 |
10390989 | Sanchez et al. | Aug 2019 | B2 |
D858144 | Fu | Sep 2019 | S |
10406039 | Mllarreal | Sep 2019 | B2 |
10407222 | Allen | Sep 2019 | B2 |
10478356 | Griffin | Nov 2019 | B2 |
10500108 | Maschino et al. | Dec 2019 | B1 |
10538366 | Pentelovitch et al. | Jan 2020 | B2 |
10569938 | Zhao et al. | Feb 2020 | B2 |
10577156 | Dagnelie et al. | Mar 2020 | B2 |
RE47930 | Cho | Apr 2020 | E |
10618721 | Vazin | Apr 2020 | B2 |
D884390 | Wang | May 2020 | S |
10669079 | Freedman et al. | Jun 2020 | B2 |
D892315 | Airy | Aug 2020 | S |
10730672 | Bertram et al. | Aug 2020 | B2 |
10737848 | Philip et al. | Aug 2020 | B2 |
10765854 | Law et al. | Sep 2020 | B2 |
10766670 | Kittmann | Sep 2020 | B2 |
10799386 | Harrison | Oct 2020 | B1 |
10806642 | Tagomori et al. | Oct 2020 | B2 |
D901214 | Hu | Nov 2020 | S |
10849799 | Nishikawa et al. | Dec 2020 | B2 |
10857025 | Davis et al. | Dec 2020 | B2 |
10865017 | Cowart et al. | Dec 2020 | B1 |
10889412 | West et al. | Jan 2021 | B2 |
10913581 | Stahlecker | Feb 2021 | B2 |
D912244 | Rehm et al. | Mar 2021 | S |
10952889 | Newton et al. | Mar 2021 | B2 |
10973378 | Ryu et al. | Apr 2021 | B2 |
10973678 | Newton et al. | Apr 2021 | B2 |
10974874 | Ragias et al. | Apr 2021 | B2 |
11000401 | Ecklund et al. | May 2021 | B2 |
D923365 | Wang | Jun 2021 | S |
11026829 | Harvie | Jun 2021 | B2 |
11027900 | Liu | Jun 2021 | B2 |
11045346 | Argent et al. | Jun 2021 | B2 |
D928946 | Sanchez et al. | Aug 2021 | S |
11160695 | Febo et al. | Nov 2021 | B2 |
11160697 | Maschino et al. | Nov 2021 | B2 |
11168420 | Kinugasa et al. | Nov 2021 | B2 |
11179506 | Barr et al. | Nov 2021 | B2 |
11226376 | Yamauchi et al. | Jan 2022 | B2 |
11253407 | Miao et al. | Feb 2022 | B2 |
11326586 | Milner et al. | May 2022 | B2 |
11369508 | Ecklund et al. | Jun 2022 | B2 |
11369524 | Hubbard et al. | Jun 2022 | B2 |
11376152 | Sanchez et al. | Jul 2022 | B2 |
11382786 | Sanchez et al. | Jul 2022 | B2 |
11382788 | Hjorth et al. | Jul 2022 | B2 |
11389318 | Radl et al. | Jul 2022 | B2 |
11395871 | Radl et al. | Jul 2022 | B2 |
11399990 | Suyama | Aug 2022 | B2 |
11426303 | Davis et al. | Aug 2022 | B2 |
11504265 | Godinez et al. | Nov 2022 | B2 |
11529252 | Glithero et al. | Dec 2022 | B2 |
11547788 | Radl et al. | Jan 2023 | B2 |
11806266 | Sanchez et al. | Nov 2023 | B2 |
11839567 | Davis et al. | Dec 2023 | B2 |
D1010109 | Ecklund et al. | Jan 2024 | S |
11857716 | Lee et al. | Jan 2024 | B2 |
11865030 | Davis et al. | Jan 2024 | B2 |
11890221 | Ulreich et al. | Feb 2024 | B2 |
11925575 | Newton | Mar 2024 | B2 |
11938053 | Austermann et al. | Mar 2024 | B2 |
11944740 | Hughett et al. | Apr 2024 | B2 |
20010037097 | Cheng et al. | Nov 2001 | A1 |
20010054426 | Knudson et al. | Dec 2001 | A1 |
20020019614 | Woon | Feb 2002 | A1 |
20020026161 | Grundke | Feb 2002 | A1 |
20020087131 | Wolff | Jul 2002 | A1 |
20020091364 | Prabhakar | Jul 2002 | A1 |
20020189992 | Schmidt et al. | Dec 2002 | A1 |
20020193760 | Thompson | Dec 2002 | A1 |
20030004436 | Schmidt et al. | Jan 2003 | A1 |
20030032931 | Grundke et al. | Feb 2003 | A1 |
20030032944 | Cawood | Feb 2003 | A1 |
20030073964 | Palumbo et al. | Apr 2003 | A1 |
20030120178 | Heki | Jun 2003 | A1 |
20030157859 | Ishikawa | Aug 2003 | A1 |
20030181880 | Schwartz | Sep 2003 | A1 |
20030195484 | Harvie | Oct 2003 | A1 |
20030204173 | Burns et al. | Oct 2003 | A1 |
20030233079 | Parks et al. | Dec 2003 | A1 |
20040006321 | Cheng et al. | Jan 2004 | A1 |
20040015141 | Cheng et al. | Jan 2004 | A1 |
20040056122 | Male et al. | Mar 2004 | A1 |
20040084465 | Luburic | May 2004 | A1 |
20040127872 | Petryk et al. | Jul 2004 | A1 |
20040128749 | Scott | Jul 2004 | A1 |
20040143229 | Easter | Jul 2004 | A1 |
20040147863 | Diaz et al. | Jul 2004 | A1 |
20040147894 | Mizutani et al. | Jul 2004 | A1 |
20040158221 | Mizutani et al. | Aug 2004 | A1 |
20040176731 | Cheng et al. | Sep 2004 | A1 |
20040176746 | Forral | Sep 2004 | A1 |
20040191919 | Unger et al. | Sep 2004 | A1 |
20040207530 | Nielsen | Oct 2004 | A1 |
20040236292 | Tazoe et al. | Nov 2004 | A1 |
20040243075 | Harvie | Dec 2004 | A1 |
20040254547 | Okabe et al. | Dec 2004 | A1 |
20050010182 | Parks et al. | Jan 2005 | A1 |
20050033248 | Machida et al. | Feb 2005 | A1 |
20050065471 | Kuntz | Mar 2005 | A1 |
20050070861 | Okabe et al. | Mar 2005 | A1 |
20050070862 | Tazoe et al. | Mar 2005 | A1 |
20050082300 | Modrell et al. | Apr 2005 | A1 |
20050097662 | Leimkuhler et al. | May 2005 | A1 |
20050101924 | Elson et al. | May 2005 | A1 |
20050119630 | Harvie | Jun 2005 | A1 |
20050137557 | Swiecicki et al. | Jun 2005 | A1 |
20050154360 | Harvie | Jul 2005 | A1 |
20050177070 | Levinson et al. | Aug 2005 | A1 |
20050197639 | Mombrinie | Sep 2005 | A1 |
20050273920 | Marinas | Dec 2005 | A1 |
20050277904 | Chase et al. | Dec 2005 | A1 |
20050279359 | LeBlanc et al. | Dec 2005 | A1 |
20060004332 | Marx | Jan 2006 | A1 |
20060015080 | Mahnensmith | Jan 2006 | A1 |
20060015081 | Suzuki et al. | Jan 2006 | A1 |
20060016778 | Park | Jan 2006 | A1 |
20060069359 | Dipalma et al. | Mar 2006 | A1 |
20060079854 | Kay et al. | Apr 2006 | A1 |
20060111648 | Vermaak | May 2006 | A1 |
20060155214 | Wightman | Jul 2006 | A1 |
20060171997 | Gruenbacher et al. | Aug 2006 | A1 |
20060200102 | Cooper | Sep 2006 | A1 |
20060229575 | Boiarski | Oct 2006 | A1 |
20060229576 | Conway et al. | Oct 2006 | A1 |
20060231648 | Male et al. | Oct 2006 | A1 |
20060235266 | Nan | Oct 2006 | A1 |
20060235359 | Marland | Oct 2006 | A1 |
20060241553 | Harvie | Oct 2006 | A1 |
20060269439 | White | Nov 2006 | A1 |
20060277670 | Baker et al. | Dec 2006 | A1 |
20070006368 | Key et al. | Jan 2007 | A1 |
20070010797 | Nishtala et al. | Jan 2007 | A1 |
20070016152 | Karpowicz et al. | Jan 2007 | A1 |
20070038194 | Wada et al. | Feb 2007 | A1 |
20070055209 | Patel et al. | Mar 2007 | A1 |
20070073252 | Forgrave | Mar 2007 | A1 |
20070117880 | Elson et al. | May 2007 | A1 |
20070118993 | Bates | May 2007 | A1 |
20070135786 | Schmidt et al. | Jun 2007 | A1 |
20070137718 | Rushlander et al. | Jun 2007 | A1 |
20070149935 | Dirico | Jun 2007 | A1 |
20070191804 | Coley | Aug 2007 | A1 |
20070214553 | Carromba et al. | Sep 2007 | A1 |
20070225663 | Watt et al. | Sep 2007 | A1 |
20070225666 | Otto | Sep 2007 | A1 |
20070225668 | Otto | Sep 2007 | A1 |
20070266486 | Ramirez | Nov 2007 | A1 |
20070282309 | Bengtson et al. | Dec 2007 | A1 |
20080004576 | Tanaka et al. | Jan 2008 | A1 |
20080015526 | Reiner et al. | Jan 2008 | A1 |
20080015527 | House | Jan 2008 | A1 |
20080033386 | Okabe et al. | Feb 2008 | A1 |
20080041869 | Backaert | Feb 2008 | A1 |
20080091153 | Harvie | Apr 2008 | A1 |
20080091158 | Yang | Apr 2008 | A1 |
20080114327 | Barge | May 2008 | A1 |
20080167634 | Kouta et al. | Jul 2008 | A1 |
20080183157 | Walters | Jul 2008 | A1 |
20080215031 | Belfort et al. | Sep 2008 | A1 |
20080234642 | Patterson et al. | Sep 2008 | A1 |
20080269703 | Collins et al. | Oct 2008 | A1 |
20080281282 | Finger et al. | Nov 2008 | A1 |
20080287894 | Van Den Heuvel et al. | Nov 2008 | A1 |
20080312550 | Nishtala et al. | Dec 2008 | A1 |
20090025717 | Pinel | Jan 2009 | A1 |
20090048570 | Jensen | Feb 2009 | A1 |
20090056003 | Ivie et al. | Mar 2009 | A1 |
20090069761 | Vogel | Mar 2009 | A1 |
20090069765 | Wortham | Mar 2009 | A1 |
20090192482 | Dodge et al. | Jul 2009 | A1 |
20090234312 | Otoole et al. | Sep 2009 | A1 |
20090251510 | Noro et al. | Oct 2009 | A1 |
20090264840 | Virginio | Oct 2009 | A1 |
20090270822 | Medeiros | Oct 2009 | A1 |
20090281510 | Fisher | Nov 2009 | A1 |
20100004612 | Thevenin | Jan 2010 | A1 |
20100058660 | Williams | Mar 2010 | A1 |
20100121289 | Parks et al. | May 2010 | A1 |
20100158168 | Murthy et al. | Jun 2010 | A1 |
20100160882 | Lowe | Jun 2010 | A1 |
20100174250 | Hu et al. | Jul 2010 | A1 |
20100185168 | Graauw et al. | Jul 2010 | A1 |
20100198172 | Wada et al. | Aug 2010 | A1 |
20100211032 | Tsai et al. | Aug 2010 | A1 |
20100234820 | Tsai et al. | Sep 2010 | A1 |
20100241104 | Gilbert | Sep 2010 | A1 |
20100263113 | Shelton et al. | Oct 2010 | A1 |
20100310845 | Bond et al. | Dec 2010 | A1 |
20110028920 | Johannison | Feb 2011 | A1 |
20110028922 | Kay et al. | Feb 2011 | A1 |
20110034889 | Smith | Feb 2011 | A1 |
20110036837 | Shang | Feb 2011 | A1 |
20110040267 | Wada et al. | Feb 2011 | A1 |
20110040271 | Rogers et al. | Feb 2011 | A1 |
20110054426 | Stewart et al. | Mar 2011 | A1 |
20110060299 | Wada et al. | Mar 2011 | A1 |
20110060300 | Weig et al. | Mar 2011 | A1 |
20110077495 | Gilbert | Mar 2011 | A1 |
20110077606 | Wilcox et al. | Mar 2011 | A1 |
20110087337 | Forsell | Apr 2011 | A1 |
20110137273 | Muellejans et al. | Jun 2011 | A1 |
20110145993 | Rader et al. | Jun 2011 | A1 |
20110152802 | Dicamillo et al. | Jun 2011 | A1 |
20110164147 | Takahashi et al. | Jul 2011 | A1 |
20110172620 | Khambatta | Jul 2011 | A1 |
20110172625 | Wada et al. | Jul 2011 | A1 |
20110202024 | Cozzens | Aug 2011 | A1 |
20110238023 | Slayton | Sep 2011 | A1 |
20110240648 | Tucker | Oct 2011 | A1 |
20110251572 | Nishtala et al. | Oct 2011 | A1 |
20110265889 | Tanaka et al. | Nov 2011 | A1 |
20110276020 | Mitsui | Nov 2011 | A1 |
20120035577 | Tomes et al. | Feb 2012 | A1 |
20120041400 | Christensen | Feb 2012 | A1 |
20120059328 | Dikeman et al. | Mar 2012 | A1 |
20120066825 | Birbara et al. | Mar 2012 | A1 |
20120103347 | Wheaton et al. | May 2012 | A1 |
20120137420 | Gordon et al. | Jun 2012 | A1 |
20120165768 | Sekiyama et al. | Jun 2012 | A1 |
20120165786 | Chappa et al. | Jun 2012 | A1 |
20120210503 | Anzivino et al. | Aug 2012 | A1 |
20120233761 | Huang | Sep 2012 | A1 |
20120245541 | Suzuki et al. | Sep 2012 | A1 |
20120245542 | Suzuki et al. | Sep 2012 | A1 |
20120245547 | Wilcox et al. | Sep 2012 | A1 |
20120253303 | Suzuki et al. | Oct 2012 | A1 |
20120271259 | Ulert | Oct 2012 | A1 |
20120296305 | Barraza Khaled et al. | Nov 2012 | A1 |
20120316522 | Carter et al. | Dec 2012 | A1 |
20120330256 | Wilcox et al. | Dec 2012 | A1 |
20130006206 | Wada et al. | Jan 2013 | A1 |
20130045651 | Esteves et al. | Feb 2013 | A1 |
20130053804 | Soerensen et al. | Feb 2013 | A1 |
20130096523 | Chang et al. | Apr 2013 | A1 |
20130138064 | Stroebech et al. | May 2013 | A1 |
20130150813 | Gordon et al. | Jun 2013 | A1 |
20130245496 | Wells et al. | Sep 2013 | A1 |
20130245586 | Jha | Sep 2013 | A1 |
20130292537 | Dirico | Nov 2013 | A1 |
20130330501 | Aizenberg et al. | Dec 2013 | A1 |
20140005647 | Shuffler et al. | Jan 2014 | A1 |
20140031774 | Bengtson | Jan 2014 | A1 |
20140039432 | Dunbar et al. | Feb 2014 | A1 |
20140157499 | Suzuki et al. | Jun 2014 | A1 |
20140171889 | Hopman et al. | Jun 2014 | A1 |
20140182051 | Tanimoto et al. | Jul 2014 | A1 |
20140196189 | Lee et al. | Jul 2014 | A1 |
20140276501 | Cisko | Sep 2014 | A1 |
20140303582 | Wright et al. | Oct 2014 | A1 |
20140316381 | Reglin | Oct 2014 | A1 |
20140325746 | Block | Nov 2014 | A1 |
20140348139 | Gomez Martinez | Nov 2014 | A1 |
20140352050 | Yao et al. | Dec 2014 | A1 |
20140371628 | Desai | Dec 2014 | A1 |
20150045757 | Lee et al. | Feb 2015 | A1 |
20150047114 | Ramirez | Feb 2015 | A1 |
20150048089 | Robertson | Feb 2015 | A1 |
20150135423 | Sharpe et al. | May 2015 | A1 |
20150157300 | Ealovega et al. | Jun 2015 | A1 |
20150209194 | Heyman | Jul 2015 | A1 |
20150290425 | Macy et al. | Oct 2015 | A1 |
20150320583 | Harvie | Nov 2015 | A1 |
20150329255 | Rzepecki | Nov 2015 | A1 |
20150342799 | Michiels et al. | Dec 2015 | A1 |
20150359660 | Harvie | Dec 2015 | A1 |
20150366699 | Nelson | Dec 2015 | A1 |
20160029998 | Brister et al. | Feb 2016 | A1 |
20160030228 | Jones | Feb 2016 | A1 |
20160038356 | Yao et al. | Feb 2016 | A1 |
20160058322 | Brister et al. | Mar 2016 | A1 |
20160060001 | Wada et al. | Mar 2016 | A1 |
20160100976 | Conway et al. | Apr 2016 | A1 |
20160106604 | Timm | Apr 2016 | A1 |
20160113809 | Kim | Apr 2016 | A1 |
20160183689 | Miner | Jun 2016 | A1 |
20160256022 | Le | Sep 2016 | A1 |
20160270982 | Raycheck et al. | Sep 2016 | A1 |
20160278662 | Brister et al. | Sep 2016 | A1 |
20160357400 | Penha et al. | Dec 2016 | A1 |
20160366699 | Zhang et al. | Dec 2016 | A1 |
20160367226 | Newton et al. | Dec 2016 | A1 |
20160367411 | Justiz et al. | Dec 2016 | A1 |
20160367726 | Gratzer | Dec 2016 | A1 |
20160374848 | Sanchez et al. | Dec 2016 | A1 |
20170007438 | Harvie | Jan 2017 | A1 |
20170014560 | Minskoff et al. | Jan 2017 | A1 |
20170100276 | Joh | Apr 2017 | A1 |
20170128638 | Giezendanner et al. | May 2017 | A1 |
20170143534 | Sanchez | May 2017 | A1 |
20170165405 | Muser et al. | Jun 2017 | A1 |
20170189225 | Voorhees et al. | Jul 2017 | A1 |
20170202692 | Laniado | Jul 2017 | A1 |
20170216081 | Accosta | Aug 2017 | A1 |
20170246026 | Laniado | Aug 2017 | A1 |
20170252014 | Siller Gonzalez et al. | Sep 2017 | A1 |
20170252202 | Sanchez et al. | Sep 2017 | A9 |
20170266031 | Sanchez et al. | Sep 2017 | A1 |
20170266658 | Bruno et al. | Sep 2017 | A1 |
20170281399 | Vanmiddendorp et al. | Oct 2017 | A1 |
20170312116 | Laniado | Nov 2017 | A1 |
20170325788 | Ealovega et al. | Nov 2017 | A1 |
20170333244 | Laniado | Nov 2017 | A1 |
20170042748 | Griffin | Dec 2017 | A1 |
20170348139 | Newton et al. | Dec 2017 | A1 |
20170354532 | Holt | Dec 2017 | A1 |
20170354551 | Gawley et al. | Dec 2017 | A1 |
20170367873 | Grannum | Dec 2017 | A1 |
20180002075 | Lee | Jan 2018 | A1 |
20180008451 | Stroebech | Jan 2018 | A1 |
20180008804 | Laniado | Jan 2018 | A1 |
20180021218 | Brosch et al. | Jan 2018 | A1 |
20180028349 | Newton et al. | Feb 2018 | A1 |
20180037384 | Archeny et al. | Feb 2018 | A1 |
20180049910 | Newton | Feb 2018 | A1 |
20180064572 | Wiltshire | Mar 2018 | A1 |
20180104131 | Killian | Apr 2018 | A1 |
20180127187 | Sewell | May 2018 | A1 |
20180193215 | Davies et al. | Jul 2018 | A1 |
20180200101 | Su | Jul 2018 | A1 |
20180228642 | Davis et al. | Aug 2018 | A1 |
20180256384 | Kasirye | Sep 2018 | A1 |
20180271694 | Fernandez et al. | Sep 2018 | A1 |
20180317892 | Catlin | Nov 2018 | A1 |
20190001030 | Braga et al. | Jan 2019 | A1 |
20190021899 | Vlet | Jan 2019 | A1 |
20190038451 | Harvie | Feb 2019 | A1 |
20190046102 | Kushnir et al. | Feb 2019 | A1 |
20190100362 | Meyers et al. | Apr 2019 | A1 |
20190133814 | Tammen et al. | May 2019 | A1 |
20190142624 | Sanchez et al. | May 2019 | A1 |
20190224036 | Sanchez et al. | Jul 2019 | A1 |
20190247222 | Ecklund et al. | Aug 2019 | A1 |
20190247223 | Brun et al. | Aug 2019 | A1 |
20190282391 | Johannes et al. | Sep 2019 | A1 |
20190314189 | Acosta | Oct 2019 | A1 |
20190314190 | Sanchez et al. | Oct 2019 | A1 |
20190321587 | Mcmenamin et al. | Oct 2019 | A1 |
20190344934 | Faerber et al. | Nov 2019 | A1 |
20190365307 | Laing et al. | Dec 2019 | A1 |
20190365561 | Newton et al. | Dec 2019 | A1 |
20200008985 | Nguyen et al. | Jan 2020 | A1 |
20200016012 | Dutkiewicz | Jan 2020 | A1 |
20200030595 | Boukidjian et al. | Jan 2020 | A1 |
20200046544 | Godinez et al. | Feb 2020 | A1 |
20200055638 | Lau et al. | Feb 2020 | A1 |
20200070392 | Huber et al. | Mar 2020 | A1 |
20200085609 | Schelch et al. | Mar 2020 | A1 |
20200085610 | Cohn et al. | Mar 2020 | A1 |
20200086090 | Von Weymarn-Schärli et al. | Mar 2020 | A1 |
20200107518 | Hiroshima et al. | Apr 2020 | A1 |
20200129322 | Leuckel | Apr 2020 | A1 |
20200171217 | Braga et al. | Jun 2020 | A9 |
20200206039 | Mclain | Jul 2020 | A1 |
20200214910 | Varona et al. | Jul 2020 | A1 |
20200216898 | Hubbell | Jul 2020 | A1 |
20200216989 | Kinugasa et al. | Jul 2020 | A1 |
20200229964 | Staali et al. | Jul 2020 | A1 |
20200231343 | Freedman et al. | Jul 2020 | A1 |
20200232841 | Satish et al. | Jul 2020 | A1 |
20200246172 | Ho | Aug 2020 | A1 |
20200246203 | Tulk et al. | Aug 2020 | A1 |
20200255189 | Liu | Aug 2020 | A1 |
20200261280 | Heyman | Aug 2020 | A1 |
20200276046 | Staali et al. | Sep 2020 | A1 |
20200306075 | Newton et al. | Oct 2020 | A1 |
20200315837 | Radl et al. | Oct 2020 | A1 |
20200315838 | Eckert | Oct 2020 | A1 |
20200315872 | Viens et al. | Oct 2020 | A1 |
20200315874 | Viens et al. | Oct 2020 | A1 |
20200331672 | Bertram et al. | Oct 2020 | A1 |
20200345332 | Duval | Nov 2020 | A1 |
20200353135 | Gregory et al. | Nov 2020 | A1 |
20200367677 | Silsby et al. | Nov 2020 | A1 |
20200369444 | Silsby et al. | Nov 2020 | A1 |
20200375781 | Staali et al. | Dec 2020 | A1 |
20200375810 | Carlin et al. | Dec 2020 | A1 |
20200385179 | Mccourt | Dec 2020 | A1 |
20200390591 | Glithero et al. | Dec 2020 | A1 |
20200390592 | Merrill | Dec 2020 | A1 |
20200405521 | Glasroe | Dec 2020 | A1 |
20210008771 | Huber et al. | Jan 2021 | A1 |
20210009323 | Markarian et al. | Jan 2021 | A1 |
20210020072 | Moehring et al. | Jan 2021 | A1 |
20210059853 | Davis et al. | Mar 2021 | A1 |
20210061523 | Bytheway | Mar 2021 | A1 |
20210069005 | Sanchez et al. | Mar 2021 | A1 |
20210069008 | Blabas et al. | Mar 2021 | A1 |
20210069009 | Im | Mar 2021 | A1 |
20210069030 | Nishikawa et al. | Mar 2021 | A1 |
20210077993 | Nazareth et al. | Mar 2021 | A1 |
20210113749 | Radl et al. | Apr 2021 | A1 |
20210121318 | Pinlac | Apr 2021 | A1 |
20210137724 | Ecklund et al. | May 2021 | A1 |
20210138190 | Erbey et al. | May 2021 | A1 |
20210154055 | Mllarreal | May 2021 | A1 |
20210170079 | Radl et al. | Jun 2021 | A1 |
20210178390 | Oueslati et al. | Jun 2021 | A1 |
20210186742 | Newton et al. | Jun 2021 | A1 |
20210212865 | Wallajapet et al. | Jul 2021 | A1 |
20210220162 | Jamison | Jul 2021 | A1 |
20210220163 | Mayrand | Jul 2021 | A1 |
20210228400 | Glithero | Jul 2021 | A1 |
20210228401 | Becker et al. | Jul 2021 | A1 |
20210228795 | Hughett et al. | Jul 2021 | A1 |
20210229877 | Ragias et al. | Jul 2021 | A1 |
20210236323 | Austermann et al. | Aug 2021 | A1 |
20210236324 | Sweeney | Aug 2021 | A1 |
20210251814 | Jönegren et al. | Aug 2021 | A1 |
20210267787 | Nazemi | Sep 2021 | A1 |
20210275343 | Sanchez et al. | Sep 2021 | A1 |
20210290454 | Yamada | Sep 2021 | A1 |
20210315727 | Jiang | Oct 2021 | A1 |
20210353450 | Sharma et al. | Nov 2021 | A1 |
20210361469 | Liu et al. | Nov 2021 | A1 |
20210369495 | Cheng et al. | Dec 2021 | A1 |
20210386925 | Hartwell et al. | Dec 2021 | A1 |
20210393433 | Godinez et al. | Dec 2021 | A1 |
20220023091 | Ecklund et al. | Jan 2022 | A1 |
20220031523 | Pierpoint | Feb 2022 | A1 |
20220039995 | Johannes et al. | Feb 2022 | A1 |
20220047410 | Walthall | Feb 2022 | A1 |
20220062028 | Mitchell et al. | Mar 2022 | A1 |
20220062029 | Johannes et al. | Mar 2022 | A1 |
20220066825 | Saraf et al. | Mar 2022 | A1 |
20220071811 | Cheng et al. | Mar 2022 | A1 |
20220071826 | Kulkarni et al. | Mar 2022 | A1 |
20220104965 | Vaninetti et al. | Apr 2022 | A1 |
20220104976 | Hoeger et al. | Apr 2022 | A1 |
20220104981 | Jones | Apr 2022 | A1 |
20220117773 | Davis et al. | Apr 2022 | A1 |
20220117774 | Meyer et al. | Apr 2022 | A1 |
20220117775 | Jones et al. | Apr 2022 | A1 |
20220133524 | Davis | May 2022 | A1 |
20220151817 | Mann | May 2022 | A1 |
20220160949 | Simiele et al. | May 2022 | A1 |
20220168159 | Triado et al. | Jun 2022 | A1 |
20220193312 | Lee et al. | Jun 2022 | A1 |
20220211536 | Johannes et al. | Jul 2022 | A1 |
20220218510 | Metzger et al. | Jul 2022 | A1 |
20220229053 | Levin et al. | Jul 2022 | A1 |
20220241106 | Johannes et al. | Aug 2022 | A1 |
20220247407 | Yamamoto et al. | Aug 2022 | A1 |
20220248836 | Cagle et al. | Aug 2022 | A1 |
20220257407 | Johannes et al. | Aug 2022 | A1 |
20220265460 | Coker | Aug 2022 | A1 |
20220265462 | Alder et al. | Aug 2022 | A1 |
20220270711 | Feala et al. | Aug 2022 | A1 |
20220273482 | Johannes et al. | Sep 2022 | A1 |
20220280357 | Jagannathan et al. | Sep 2022 | A1 |
20220287689 | Johannes | Sep 2022 | A1 |
20220296408 | Evans et al. | Sep 2022 | A1 |
20220305191 | Joseph et al. | Sep 2022 | A1 |
20220313222 | Austermann et al. | Oct 2022 | A1 |
20220313474 | Kriscovich et al. | Oct 2022 | A1 |
20220331170 | Erdem et al. | Oct 2022 | A1 |
20220339024 | Johannes et al. | Oct 2022 | A1 |
20220354685 | Davis et al. | Nov 2022 | A1 |
20220362049 | Austermann et al. | Nov 2022 | A1 |
20220370231 | Wang et al. | Nov 2022 | A1 |
20220370234 | Hughett et al. | Nov 2022 | A1 |
20220370235 | Johannes et al. | Nov 2022 | A1 |
20220370237 | Parmar et al. | Nov 2022 | A1 |
20220387001 | Askenazi et al. | Dec 2022 | A1 |
20220395390 | Brooks | Dec 2022 | A1 |
20220395391 | Saunders et al. | Dec 2022 | A1 |
20230018845 | Lee | Jan 2023 | A1 |
20230020563 | Sharma et al. | Jan 2023 | A1 |
20230031640 | Hughett et al. | Feb 2023 | A1 |
20230037159 | Brennan et al. | Feb 2023 | A1 |
20230052238 | Oluwasogo | Feb 2023 | A1 |
20230062944 | Vollenberg et al. | Mar 2023 | A1 |
20230062994 | Ecklund et al. | Mar 2023 | A1 |
20230070347 | Watson et al. | Mar 2023 | A1 |
20230073708 | Xu et al. | Mar 2023 | A1 |
20230089032 | Hughett et al. | Mar 2023 | A1 |
20230099821 | Radl et al. | Mar 2023 | A1 |
20230099991 | Bianchi et al. | Mar 2023 | A1 |
20230105001 | Whittome et al. | Apr 2023 | A1 |
20230110577 | Choi | Apr 2023 | A1 |
20230138269 | Abdelal et al. | May 2023 | A1 |
20230145365 | Martin et al. | May 2023 | A1 |
20230155253 | Yin et al. | May 2023 | A1 |
20230210504 | Kuroda et al. | Jul 2023 | A1 |
20230218426 | Hughett | Jul 2023 | A1 |
20230240884 | Davis et al. | Aug 2023 | A1 |
20230248562 | Sanchez et al. | Aug 2023 | A1 |
20230248564 | Mann et al. | Aug 2023 | A1 |
20230255812 | Sanchez et al. | Aug 2023 | A1 |
20230255813 | Sanchez et al. | Aug 2023 | A1 |
20230255815 | Newton | Aug 2023 | A1 |
20230263650 | Sanchez et al. | Aug 2023 | A1 |
20230263655 | Johannes et al. | Aug 2023 | A1 |
20230277362 | Davis et al. | Sep 2023 | A1 |
20230285178 | Sanchez et al. | Sep 2023 | A1 |
20230293339 | James | Sep 2023 | A1 |
20230301846 | Greenwood | Sep 2023 | A1 |
20230355423 | Stevenson et al. | Nov 2023 | A1 |
20230404791 | Ecklund et al. | Dec 2023 | A1 |
20240008444 | Su et al. | Jan 2024 | A1 |
20240009023 | Johannes et al. | Jan 2024 | A1 |
20240024170 | Scott | Jan 2024 | A1 |
20240041638 | Johannes et al. | Feb 2024 | A1 |
20240058161 | Ulreich et al. | Feb 2024 | A1 |
20240065881 | Kuroda et al. | Feb 2024 | A1 |
20240099874 | Sanchez et al. | Mar 2024 | A1 |
20240110318 | Bendt et al. | Apr 2024 | A1 |
20240123134 | Kharkar et al. | Apr 2024 | A1 |
Number | Date | Country |
---|---|---|
2018216821 | Aug 2019 | AU |
2021299304 | Feb 2023 | AU |
2165286 | Sep 1999 | CA |
2354132 | Jun 2000 | CA |
2359091 | Sep 2003 | CA |
2488867 | Aug 2007 | CA |
3050918 | Aug 2018 | CA |
3098571 | Nov 2019 | CA |
2269203 | Dec 1997 | CN |
1332620 | Jan 2002 | CN |
1533755 | Oct 2004 | CN |
1602825 | Apr 2005 | CN |
1720888 | Jan 2006 | CN |
2936204 | Aug 2007 | CN |
101262836 | Sep 2008 | CN |
101522148 | Sep 2009 | CN |
102159159 | Aug 2011 | CN |
202184840 | Apr 2012 | CN |
102481441 | May 2012 | CN |
202463712 | Oct 2012 | CN |
103533968 | Jan 2014 | CN |
103717180 | Apr 2014 | CN |
204562697 | Aug 2015 | CN |
105411783 | Mar 2016 | CN |
105451693 | Mar 2016 | CN |
105534632 | May 2016 | CN |
205849719 | Jan 2017 | CN |
106726089 | May 2017 | CN |
107847384 | Mar 2018 | CN |
107920912 | Apr 2018 | CN |
209285902 | Aug 2019 | CN |
110381883 | Oct 2019 | CN |
211198839 | Aug 2020 | CN |
112566550 | Mar 2021 | CN |
112603184 | Apr 2021 | CN |
114007493 | Feb 2022 | CN |
114375187 | Apr 2022 | CN |
116096332 | May 2023 | CN |
79818 | Oct 1893 | DE |
1516466 | Jun 1969 | DE |
2721330 | Nov 1977 | DE |
2742298 | Mar 1978 | DE |
9407554.9 | May 1995 | DE |
4443710 | Jun 1995 | DE |
4416094 | Nov 1995 | DE |
4236097 | Oct 1996 | DE |
19619597 | Nov 1997 | DE |
102005037762 | Sep 2006 | DE |
102011103783 | Dec 2012 | DE |
202015104597 | Jul 2016 | DE |
9600118 | Nov 1996 | DK |
0032138 | Jul 1981 | EP |
0066070 | Dec 1982 | EP |
0068712 | Jan 1983 | EP |
0140470 | May 1985 | EP |
0140471 | May 1988 | EP |
0274753 | Jul 1988 | EP |
0119143 | Nov 1988 | EP |
0483592 | May 1992 | EP |
0610638 | Aug 1994 | EP |
0613355 | Sep 1994 | EP |
0613355 | Jan 1997 | EP |
0787472 | Aug 1997 | EP |
0966936 | Dec 1999 | EP |
0987293 | Mar 2000 | EP |
1063953 | Jan 2001 | EP |
0653928 | Oct 2002 | EP |
1332738 | Aug 2003 | EP |
1382318 | Jan 2004 | EP |
1089684 | Oct 2004 | EP |
1616542 | Jan 2006 | EP |
1382318 | May 2006 | EP |
1063953 | Jan 2007 | EP |
1872752 | Jan 2008 | EP |
2180907 | May 2010 | EP |
2380532 | Oct 2011 | EP |
2389908 | Nov 2011 | EP |
2601916 | Jun 2013 | EP |
2676643 | Dec 2013 | EP |
2997950 | Mar 2016 | EP |
2879534 | Mar 2017 | EP |
3424471 | Jan 2019 | EP |
3169292 | Nov 2019 | EP |
3753492 | Dec 2020 | EP |
3788992 | Mar 2021 | EP |
3576689 | Mar 2022 | EP |
3752110 | Mar 2022 | EP |
3787570 | Mar 2022 | EP |
4025163 | Jul 2022 | EP |
3463180 | Mar 2023 | EP |
1011517 | Dec 1965 | GB |
1467144 | Mar 1977 | GB |
2106395 | Apr 1983 | GB |
2148126 | May 1985 | GB |
2171315 | Aug 1986 | GB |
2181953 | May 1987 | GB |
2148126 | Jul 1987 | GB |
2191095 | Dec 1987 | GB |
2199750 | Jul 1988 | GB |
2260907 | May 1993 | GB |
2462267 | Feb 2010 | GB |
2469496 | Oct 2010 | GB |
2490327 | Oct 2012 | GB |
2507318 | Apr 2014 | GB |
2612752 | May 2023 | GB |
201800009129 | Apr 2020 | IT |
S498638 | Jan 1974 | JP |
S5410596 | Jan 1979 | JP |
S5410596 | May 1979 | JP |
S55155618 | Dec 1980 | JP |
S5888596 | Jun 1983 | JP |
S63107780 | Jul 1988 | JP |
H0267530 | Mar 1990 | JP |
H02103871 | Apr 1990 | JP |
H02131422 | May 1990 | JP |
H02131422 | Nov 1990 | JP |
H0460220 | Feb 1992 | JP |
H05123349 | May 1993 | JP |
H05123350 | May 1993 | JP |
3087938 | Oct 1995 | JP |
H085630 | Jan 1996 | JP |
H1040141 | Feb 1998 | JP |
H10225430 | Aug 1998 | JP |
H11113946 | Apr 1999 | JP |
H11290365 | Oct 1999 | JP |
2000116690 | Apr 2000 | JP |
2000185068 | Jul 2000 | JP |
2001054531 | Feb 2001 | JP |
2001054531 | Feb 2001 | JP |
2001070331 | Mar 2001 | JP |
2001224616 | Aug 2001 | JP |
2001276107 | Oct 2001 | JP |
2001276108 | Oct 2001 | JP |
2002028173 | Jan 2002 | JP |
2003505152 | Feb 2003 | JP |
2003180722 | Jul 2003 | JP |
2004130056 | Apr 2004 | JP |
2004267530 | Sep 2004 | JP |
2005066011 | Mar 2005 | JP |
2005066325 | Mar 2005 | JP |
2005518237 | Jun 2005 | JP |
3749097 | Dec 2005 | JP |
2006026108 | Feb 2006 | JP |
3123547 | Jun 2006 | JP |
2006136492 | Jun 2006 | JP |
2006204868 | Aug 2006 | JP |
2007044494 | Feb 2007 | JP |
3132659 | May 2007 | JP |
4039641 | Nov 2007 | JP |
2009509570 | Mar 2009 | JP |
2010081981 | Apr 2010 | JP |
4640772 | Dec 2010 | JP |
2010536439 | Dec 2010 | JP |
4747166 | May 2011 | JP |
2011087823 | May 2011 | JP |
4801218 | Aug 2011 | JP |
2011218130 | Nov 2011 | JP |
2011224070 | Nov 2011 | JP |
2012523869 | Oct 2012 | JP |
2013238608 | Nov 2013 | JP |
2014521960 | Aug 2014 | JP |
2015092945 | May 2015 | JP |
3198994 | Jul 2015 | JP |
2019525811 | Sep 2019 | JP |
2021120686 | Aug 2021 | JP |
2021522009 | Aug 2021 | JP |
7129493 | Aug 2022 | JP |
2023532132 | Jul 2023 | JP |
200290061 | Sep 2002 | KR |
20030047451 | Jun 2003 | KR |
20140039485 | Apr 2014 | KR |
101432639 | Aug 2014 | KR |
20180106659 | Oct 2018 | KR |
20180108774 | Oct 2018 | KR |
2068717 | Jun 2013 | PT |
8101957 | Jul 1981 | WO |
8804558 | Jun 1988 | WO |
9104714 | Apr 1991 | WO |
9104714 | Jun 1991 | WO |
9220299 | Feb 1993 | WO |
9307839 | Apr 1993 | WO |
9309736 | May 1993 | WO |
9309736 | Jun 1993 | WO |
9514448 | Jun 1995 | WO |
9600096 | Jan 1996 | WO |
9634636 | Nov 1996 | WO |
9817211 | Apr 1998 | WO |
9830336 | Jul 1998 | WO |
0000112 | Jan 2000 | WO |
0000113 | Jan 2000 | WO |
0025651 | May 2000 | WO |
0033773 | Jun 2000 | WO |
0057784 | Oct 2000 | WO |
0069377 | Nov 2000 | WO |
0079497 | Dec 2000 | WO |
0145618 | Jun 2001 | WO |
0145621 | Jun 2001 | WO |
02094160 | Nov 2002 | WO |
03013967 | Feb 2003 | WO |
03024824 | Mar 2003 | WO |
03055423 | Jul 2003 | WO |
03071931 | Sep 2003 | WO |
03079942 | Oct 2003 | WO |
03071931 | Feb 2004 | WO |
2004019836 | Mar 2004 | WO |
2004024046 | Mar 2004 | WO |
2005051252 | Jun 2005 | WO |
2005074571 | Sep 2005 | WO |
2005089687 | Sep 2005 | WO |
2005107661 | Nov 2005 | WO |
2006021220 | Mar 2006 | WO |
2006037140 | Apr 2006 | WO |
2007005851 | Jan 2007 | WO |
2007007845 | Jan 2007 | WO |
2007042823 | Apr 2007 | WO |
2007055651 | May 2007 | WO |
2006098950 | Nov 2007 | WO |
2007134608 | Nov 2007 | WO |
2007128156 | Feb 2008 | WO |
2008026106 | Mar 2008 | WO |
2008078117 | Jul 2008 | WO |
2008104019 | Sep 2008 | WO |
2008141471 | Nov 2008 | WO |
2009004368 | Jan 2009 | WO |
2009004369 | Jan 2009 | WO |
2009052496 | Apr 2009 | WO |
2009052502 | Apr 2009 | WO |
2009007702 | Jul 2009 | WO |
2009101738 | Aug 2009 | WO |
2010058192 | May 2010 | WO |
2010030122 | Jul 2010 | WO |
2010101915 | Jan 2011 | WO |
2011018132 | Feb 2011 | WO |
2011018133 | Feb 2011 | WO |
2011024864 | Mar 2011 | WO |
2011054118 | May 2011 | WO |
2011079132 | Jun 2011 | WO |
2011107972 | Sep 2011 | WO |
2011108972 | Sep 2011 | WO |
2011117292 | Sep 2011 | WO |
2011123219 | Oct 2011 | WO |
2011132043 | Oct 2011 | WO |
2012012908 | Feb 2012 | WO |
2012065274 | May 2012 | WO |
2012097462 | Jul 2012 | WO |
2012098796 | Jul 2012 | WO |
2012101288 | Aug 2012 | WO |
2012175916 | Dec 2012 | WO |
2013018435 | Feb 2013 | WO |
2013033429 | Mar 2013 | WO |
2013055434 | Apr 2013 | WO |
2013082397 | Jun 2013 | WO |
2013103291 | Jul 2013 | WO |
2013131109 | Sep 2013 | WO |
2013167478 | Nov 2013 | WO |
2013177716 | Dec 2013 | WO |
2014041534 | Mar 2014 | WO |
2014046420 | Mar 2014 | WO |
2014118518 | Aug 2014 | WO |
2014160852 | Oct 2014 | WO |
2015023599 | Feb 2015 | WO |
2015052348 | Apr 2015 | WO |
2015068384 | May 2015 | WO |
2015169403 | Nov 2015 | WO |
2015170307 | Nov 2015 | WO |
2015197462 | Dec 2015 | WO |
2016051385 | Apr 2016 | WO |
2016055989 | Apr 2016 | WO |
2016071894 | May 2016 | WO |
2016103242 | Jun 2016 | WO |
2016116915 | Jul 2016 | WO |
2016124203 | Aug 2016 | WO |
2016139448 | Sep 2016 | WO |
2016166562 | Oct 2016 | WO |
2016167535 | Oct 2016 | WO |
2016191574 | Dec 2016 | WO |
2016200088 | Dec 2016 | WO |
2016200361 | Dec 2016 | WO |
2016204731 | Dec 2016 | WO |
2017001532 | Jan 2017 | WO |
2017001846 | Jan 2017 | WO |
2017075226 | May 2017 | WO |
2017152198 | Sep 2017 | WO |
2017153357 | Sep 2017 | WO |
2017162559 | Sep 2017 | WO |
2017205446 | Nov 2017 | WO |
2017209779 | Dec 2017 | WO |
2017210524 | Dec 2017 | WO |
2018022414 | Feb 2018 | WO |
2018044781 | Mar 2018 | WO |
2018056953 | Mar 2018 | WO |
2018090550 | May 2018 | WO |
2018138513 | Aug 2018 | WO |
2018144318 | Aug 2018 | WO |
2018144463 | Aug 2018 | WO |
2018150263 | Aug 2018 | WO |
2018150268 | Aug 2018 | WO |
2018152156 | Aug 2018 | WO |
2018183791 | Oct 2018 | WO |
2018150267 | Nov 2018 | WO |
2018235026 | Dec 2018 | WO |
2018235065 | Dec 2018 | WO |
2019004404 | Jan 2019 | WO |
2019041005 | Mar 2019 | WO |
2019044217 | Mar 2019 | WO |
2019044218 | Mar 2019 | WO |
2019044219 | Mar 2019 | WO |
2019065541 | Apr 2019 | WO |
2019096845 | May 2019 | WO |
2019150385 | Aug 2019 | WO |
2019161094 | Aug 2019 | WO |
2019188566 | Oct 2019 | WO |
2019190593 | Oct 2019 | WO |
2019212949 | Nov 2019 | WO |
2019212950 | Nov 2019 | WO |
2019212951 | Nov 2019 | WO |
2019212952 | Nov 2019 | WO |
2019212954 | Nov 2019 | WO |
2019212955 | Nov 2019 | WO |
2019212956 | Nov 2019 | WO |
2019214787 | Nov 2019 | WO |
2019214788 | Nov 2019 | WO |
2019226826 | Nov 2019 | WO |
2019239433 | Dec 2019 | WO |
2020000994 | Jan 2020 | WO |
2020020618 | Jan 2020 | WO |
2020038822 | Feb 2020 | WO |
2020088409 | May 2020 | WO |
2020049394 | Jun 2020 | WO |
2020120657 | Jun 2020 | WO |
2020152575 | Jul 2020 | WO |
2020182923 | Sep 2020 | WO |
2020204967 | Oct 2020 | WO |
2020205939 | Oct 2020 | WO |
2020209898 | Oct 2020 | WO |
2020242790 | Dec 2020 | WO |
2020251893 | Dec 2020 | WO |
2020256865 | Dec 2020 | WO |
2021007144 | Jan 2021 | WO |
2021007345 | Jan 2021 | WO |
2021010844 | Jan 2021 | WO |
2021016026 | Jan 2021 | WO |
2021016300 | Jan 2021 | WO |
2021025919 | Feb 2021 | WO |
2021034886 | Feb 2021 | WO |
2021041123 | Mar 2021 | WO |
2021046501 | Mar 2021 | WO |
2021086868 | May 2021 | WO |
2021094352 | May 2021 | WO |
2021094639 | May 2021 | WO |
2021097067 | May 2021 | WO |
2021102296 | May 2021 | WO |
2021107025 | Jun 2021 | WO |
2021138411 | Jul 2021 | WO |
2021138414 | Jul 2021 | WO |
2021154686 | Aug 2021 | WO |
2021155206 | Aug 2021 | WO |
2021170075 | Sep 2021 | WO |
2021173436 | Sep 2021 | WO |
2021188817 | Sep 2021 | WO |
2021195384 | Sep 2021 | WO |
2021205995 | Oct 2021 | WO |
2021207621 | Oct 2021 | WO |
2021211568 | Oct 2021 | WO |
2021211801 | Oct 2021 | WO |
2021211914 | Oct 2021 | WO |
2021216419 | Oct 2021 | WO |
2021216422 | Oct 2021 | WO |
2021231532 | Nov 2021 | WO |
2021247523 | Dec 2021 | WO |
2021257202 | Dec 2021 | WO |
2022006256 | Jan 2022 | WO |
2022031943 | Feb 2022 | WO |
2022035745 | Feb 2022 | WO |
2022051360 | Mar 2022 | WO |
2022054613 | Mar 2022 | WO |
2022066704 | Mar 2022 | WO |
2022067392 | Apr 2022 | WO |
2022069950 | Apr 2022 | WO |
2022071429 | Apr 2022 | WO |
2022076322 | Apr 2022 | WO |
2022076427 | Apr 2022 | WO |
2022086898 | Apr 2022 | WO |
2022090199 | May 2022 | WO |
2022098536 | May 2022 | WO |
2022099087 | May 2022 | WO |
2022101999 | May 2022 | WO |
2022115692 | Jun 2022 | WO |
2022125685 | Jun 2022 | WO |
2022140545 | Jun 2022 | WO |
2022145231 | Jul 2022 | WO |
2022150360 | Jul 2022 | WO |
2022150463 | Jul 2022 | WO |
2022159392 | Jul 2022 | WO |
2022170182 | Aug 2022 | WO |
2022182385 | Sep 2022 | WO |
2022187152 | Sep 2022 | WO |
2022192188 | Sep 2022 | WO |
2022192347 | Sep 2022 | WO |
2022216507 | Oct 2022 | WO |
2022222030 | Oct 2022 | WO |
2023286058 | Jan 2023 | WO |
2023014639 | Feb 2023 | WO |
2023014641 | Feb 2023 | WO |
2023018475 | Feb 2023 | WO |
2023023777 | Mar 2023 | WO |
2023034453 | Mar 2023 | WO |
2023038945 | Mar 2023 | WO |
2023038950 | Mar 2023 | WO |
2023049109 | Mar 2023 | WO |
2023049175 | Mar 2023 | WO |
2023086394 | May 2023 | WO |
2023149884 | Aug 2023 | WO |
2023149902 | Aug 2023 | WO |
2023149903 | Aug 2023 | WO |
2023154390 | Aug 2023 | WO |
2023191764 | Oct 2023 | WO |
2023244238 | Dec 2023 | WO |
2024058788 | Mar 2024 | WO |
Entry |
---|
US 9,908,683 B2, 03/2018, Sandhausen et al. (withdrawn) |
Advisory Action for U.S. Appl. No. 14/952,591 dated Jun. 1, 2018. |
AMXDmax In-Flight Bladder Relief; Omni Medical 2015; Omni Medical Systems, Inc. |
Corrected International Search Report and Written Opinion for International Application No. PCT/US2017/043025 dated Jan. 11, 2018. |
Final Office Action for U.S. Appl. No. 14/947,759 dated Apr. 8, 2016. |
Final Office Action for U.S. Appl. No. 14/952,591 dated Feb. 23, 2018. |
Final Office Action for U.S. Appl. No. 15/171,968 dated Mar. 19, 2019. |
Final Office Action for U.S. Appl. No. 15/221,106 dated Jan. 23, 2019. |
Final Office Action for U.S. Appl. No. 15/238,427 dated Jan. 2, 2019. |
Final Office Action for U.S. Application No. 15/260, 103 dated Feb. 14, 2019. |
International Search Report and Written Opinion for International Application No. PCT/US2017/043025 dated Oct. 18, 2017. |
International Search Report and Written Opinion for International Application No. PCT/US2018/015968 dated Apr. 6, 2018. |
International Search Report and Written Opinion for International Patent Application No. PCT/US16/49274, dated Dec. 1, 2016. |
International Search Report and Written Opinion for International Patent Application No. PCT/US2017/035625, dated Aug. 15, 2017. |
Issue Notification for U.S. Appl. No. 15/611,587 dated Feb. 20, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/947,759, dated Mar. 17, 2016. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Aug. 1, 2017. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Mar. 21, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Sep. 28, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated Jun. 12, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/221,106 dated Jun. 5, 2018. N |
on-Final Office Action for U.S. Appl. No. 15/238,427 dated Aug. 8, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/260, 103 dated Sep. 26, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/611,587 dated Jul. 13, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/611,587 dated Dec. 29, 2017. |
Notice of Allowance for U.S. Appl. No. 15/611,587 dated Dec. 21, 2018. |
U.S. Appl. No. 15/171,968, filed Jun. 2, 2016. |
U.S. Application No. 15/221, 106 filed Jul. 27, 2016. |
U.S. Appl. No. 62/665,297, filed May 1, 2018. |
U.S. Appl. No. 62/665,302, filed May 1, 2018. |
U.S. Appl. No. 62/665,317, filed May 1, 2018. |
U.S. Appl. No. 62/665,321, filed May 1, 2018. |
U.S. Appl. No. 62/665,331, filed May 1, 2018. |
U.S. Appl. No. 62/665,335, filed May 1, 2018. |
“Male Urinary Pouch External Collection Device”, http://www.hollister.com/en/products/Continence-Care-Products/Urine-Collectors/Urine-Collection-Accessories/Male-Urinary-Pouch-External-Collection-Device, last accessed Feb. 8, 2018. |
“Step by Step How Ur24 WorksHome”, http://medicalpatentur24.com, last accessed Dec. 6, 2017, Aug. 30, 2017, 4 pages. |
Parmar, “10 Finalists Chosen for Dare-to-Dream Medtech Design Challenge (PUreWick),” Design Services, Nov. 10, 2014 (3 pages). |
Purewick, “Incontinence Relief for Women” Presentation, (7 pages), Sep. 23, 2015. |
Pytlik, “Super Absorbent Polymers,” University of Buffalo http://www.courses.sens.buffalo.edu/ce435/Diapers/Diapers.html, accessed on Feb. 17, 2017. |
Corrected Notice of Allowability for U.S. Appl. No. 15/612,325 dated Mar. 17, 2021. |
Final Office Action for U.S. Appl. No. 14/952,591 dated Nov. 27, 2020. |
Final Office Action for U.S. Appl. No. 15/612,325 dated Sep. 17, 2020. |
Final Office Action for U.S. Appl. No. 16/904,868 dated Mar. 26, 2021. |
Issue Notification for U.S. Appl. No. 15/171,968 dated Mar. 3, 2021. |
Issue Notification for U.S. Appl. No. 15/612,325 dated Mar. 24, 2021. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated May 11, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/899,956 dated Oct. 16, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Nov. 25, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Dec. 2, 2020. |
Non-Final Office Action for U.S. Appl. No. 17/088,272 dated Jan. 25, 2021. |
Non-Final Office Action for U.S. Appl. No. 29/694,002 dated Jun. 24, 2020. |
Notice of Allowance for U.S. Appl. No. 15/171,968 dated Feb. 16, 2021. |
Notice of Allowance for U.S. Appl. No. 15/171,968 dated Nov. 6, 2020. |
Notice of Allowance for U.S. Appl. No. 15/612,325 dated Feb. 19, 2021. |
Notice of Allowance for U.S. Appl. No. 15/612,325 dated Jan. 21, 2021. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Jul. 10, 2020. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated May 14, 2020. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Sep. 29, 2020. |
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Jan. 29, 2021. |
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Oct. 16, 2020. |
Notice to File Missing Parts for U.S. Appl. No. 17/179,116 dated Mar. 3, 2021. |
U.S. Appl. No. 16/904,868, filed Jun. 18, 2020. |
U.S. Appl. No. 16/905,400, filed Jun. 18, 2020. |
U.S. Appl. No. 17/051,550, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,554, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,585, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,600, filed Oct. 29, 2020. |
U.S. Appl. No. 17/088,272, filed Nov. 3, 2020. |
U.S. Appl. No. 17/179,116, filed Feb. 18, 2021. |
U.S. Appl. No. 63/134,287, filed Jan. 6, 2021. |
U.S. Appl. No. 63/134,632, filed Jan. 7, 2021. |
U.S. Appl. No. 63/148,723, filed Feb. 12, 2021. |
Memorandum Order, Feb. 2021, 14 pgs. |
Sage's Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; U.S. Pat. No. 10,226,375; and U.S. Pat. No. 10,390,989, May 29, 2020, 193 pages. |
Sage's Supplemental and Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; U.S. Pat. No. 10,226,375; U.S. Pat. No. 10,390,989 and Initial Invalidity Contentions Regarding U.S. Pat. No. 10,376,407, Aug. 21, 2020, 277 pages. |
Sage's Second Supplemental Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508, U.S. Pat. No. 10,226,375, U.S. Pat. No. 10,390,989, and U.S. Pat. No. 10,376,407, 292 pages. |
Excerpts from the 508 (U.S. Pat. No. 8,278,508) Patent's Prosecution History, 2020, 99 pages. |
Plaintiff's Opening Claim Construction Brief, Case No. 19-1508-MN, Oct. 16, 2020, 26 pages. |
Plaintiff's Identification of Claim Terms and Proposed Constructions, Case No. 19-1508-MN, 3 pages. |
PureWick's Response to Interrogatory No. 9 in PureWick, LLC v. Sage Products, LLC, Case No. 19-1508-MN, Mar. 23, 2020, 6 pages. |
Sage's Preliminary Identification of Claim Elements and Proposed Constructions for U.S. Pat. Nos. 8,287,508, U.S. Pat. No. 10,226,376, U.S. Pat. No. 10,390,989 and U.S. Pat. No. 10,376,407, Case No. 19-1508-MN, 7 pages. |
Decision Granting Institution of Inter Partes Review for U.S. Pat. No. 8,287,508, Case No. 2020-01426, Feb. 17, 2021, 39 pages. |
Corrected Certificate of Service, Case No. IPR2020-01426, U.S. Pat. No. 8,287,508, 2020, 2 pages. |
Declaration of Diane K. Newman Curriculum Vitae, Petition for Interparties Review, 2020, pp. 1-199. |
“3 Devices Take Top Honors in Dare-To-Dream Medtech Design Contest”, R+D Digest, Nov. 2013, 1 page. |
“Advanced Mission Extender Device (AMDX) Products”, Omni Medical Systems, Inc., 15 pages. |
“AMXD Control Starter Kit Brochure”, https://www.omnimedicalsys.com/index.php?page=products, Omni Medical, 8 pages. |
“AMXDX—Advanced Mission Extender Device Brochure”, Omni Medical, Omni Brochure—http://www.omnimedicalsys.com/uploads/AMXDFixedWing.pdf, 2 pages. |
“High Absorbancy Cellulose Acetate Electrospun Nanofibers for Feminine Hygiene Application”, https://www.sciencedirect.com/science/article/abs/pii/S2352940716300701?via%3Dihub, Jul. 2016, 3 pages. |
“How Period Panties Work”, www.shethinx.com/pages/thinx-itworks, 2020, 10 pages. |
“Hydrogel properties of electrospun polyvinylpyrrolidone and polyvinylpyrrolidone/poly(acrylic acid) blend nanofibers”, https://pubs.rsc.org/en/content/articlelanding/2015/ra/c5ra07514a#!divAbstract, 2015, 5 pages. |
“In Flight Bladder Relief”, Omni Medical, Omni Presentation https://www.omnimedicalsys.com/uploads/AMXDmax_HSD.pdf, 14 pages. |
“Making Women's Sanitary Products Safer and Cheaper”, https://www.elsevier.com/connect/making-womens-sanitary-products-safer-and-cheaper, Sep. 2016, 10 pages. |
“Novel Nanofibers Make Safe and Effective Absorbent for Sanitary Products” https://www.materialstoday.com/nanomaterials/news/nanofibers-make-safe-and-effective-absorbent/, Oct. 2016, 3 pages. |
“Research and Development Work Relating to Assistive Technology Jun. 2005”, British Department of Health, Nov. 2006, 40 pages. |
“Underwear that absorbs your period”, Thinx!, https://www.shethinx.com/pages/thinx-it-works last accessed Jun. 24, 2020, 7 pages. |
“User & Maintenance Guide”, Omni Medical, 2007, 16 pages. |
“Winners Announced for Dare-to-Dream Medtech Design Challenge”, https://www.mddionline.com/design-engineering/winners-announced- dare-dream-medtech-design-challenge, MD&DI, 2014, 4 pages. |
Hollister, Female Urinary and Pouch and Male Urinary Pouch Brochure, 2011, 1 page. |
Hollister, “Retracted Penis Pouch by Hollister”, Vitality Medical.com, https://www.vitalitymedical.com/hollister-retracted-penis-pouch.html last accessed Jun. 24, 2020, 6 pages. |
Macaulay, et al., “A Noninvasive Continence Management System: Development and Evaluation of a Novel Toileting Device for Women”, The Wound, Ostomy and Continence Nurses Society, vol. 34 No. 6, 2007, pp. 641-648. |
Newman, et al., “The Urinary Incontinence Sourcebook”, Petition for Interparties Review, 1997, 23 pages. |
Newton, et al., “Measuring Safety, Effectiveness and Ease of Use of PureWick in the Management of Urinary Incontinence in Bedbound Women: Case Studies”, Jan. 8, 2016, 11 pages. |
Sachtman, “New Relief for Pilots? It Depends”, Wired, https://www.wired.com/2008/05/pilot-relief/, 2008, 2 pages. |
Advisory Action for U.S. Appl. No. 14/722,613 dated Mar. 4, 2019. |
Advisory Action for U.S. Appl. No. 15/238,427 dated Apr. 10, 2019. |
Corrected Notice of Allowability for U.S. Appl. No. 15/221,106 dated Jul. 2, 2019. |
Final Office Action for U.S. Appl. No. 14/722,613 dated Nov. 29, 2018. |
Final Office Action for U.S. Appl. No. 14/952,591 dated Nov. 1, 2019. |
Final Office Action for U.S. Appl. No. 15/171,968 dated Feb. 14, 2020. |
Final Office Action for U.S. Appl. No. 29/624,661 dated Feb. 18, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029608 dated Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029609 dated Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029610 dated Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029611 dated Jul. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029613 dated Jul. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029614 dated Sep. 26, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029616 dated Aug. 30, 2019. |
Issue Notification for U.S. Appl. No. 15/221,106 dated Jul. 24, 2019. |
Issue Notification for U.S. Appl. No. 15/238,427 dated Jul. 24, 2019. |
Issue Notification for U.S. Appl. No. 15/260,103 dated Aug. 7, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/592,591 dated Mar. 20, 2020. |
Non-Final Office Action for U.S. Appl. No. 14/722,613 dated Jun. 13, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Mar. 20, 2020. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated Aug. 20, 2019. |
Non-Final Office Action for U.S. Appl. No. 15/612,325 dated Mar. 19, 2020. |
Non-Final Office Action for U.S. Appl. No. 29/624,661 dated Jul. 18, 2019. |
Notice of Allowance for U.S. Appl. No. 15/221,106 dated May 1, 2019. |
Notice of Allowance for U.S. Appl. No. 15/238,427 dated May 23, 2019. |
Notice of Allowance for U.S. Appl. No. 15/260,103 dated Jun. 7, 2019. |
U.S. Appl. No. 16/433,773, filed Jun. 6, 2019. |
U.S. Appl. No. 16/449,039, filed Jun. 21, 2019. |
U.S. Application No. 16/452, 145 filed Jun. 25, 2019. |
U.S. Appl. No. 16/452,258, filed Jun. 25, 2019. |
U.S. Appl. No. 16/478,180, filed Jul. 16, 2019. |
U.S. Appl. No. 62/452,437, filed Jan. 31, 2017. |
U.S. Appl. No. 62/994,912, filed Mar. 26, 2020. |
Defendant and Counterclaim Plaintiff Sage Products, LLC's Answer, Defenses, and Counterclaims to Plaintiff's Amended Complaint, Nov. 1, 2019. |
Advisory Action for U.S. Appl. No. 16/899,956 dated Jul. 9, 2021. |
Advisory Action for U.S. Appl. No. 16/904,868 dated Jul. 2, 2021. |
Advisory Action for U.S. Appl. No. 16/904,868 mailed Jun. 15, 2022. |
Advisory Action for U.S. Appl. No. 16/905,400 mailed Feb. 16, 2022. |
Advisory Action for U.S. Appl. No. 16/905,400 mailed Jun. 9, 2021. |
Corrected Notice of Allowability for U.S. Appl. No. 17/330,657 mailed Dec. 9, 2021. |
Final Office Action for U.S. Application No. 16/452, 145 mailed Mar. 25, 2022. |
Final Office Action for U.S. Appl. No. 16/452,258 mailed Jun. 14, 2022. |
Final Office Action for U.S. Application No. 16/478, 180 mailed Jun. 22, 2022. |
Final Office Action for U.S. Appl. No. 16/899,956 mailed Apr. 19, 2021. |
Final Office Action for U.S. Appl. No. 16/904,868 mailed Mar. 10, 2022. |
Final Office Action for U.S. Appl. No. 16/905,400 mailed Apr. 6, 2021. |
Final Office Action for U.S. Appl. No. 16/905,400 mailed Dec. 9, 2021. |
Final Office Action for U.S. Appl. No. 17/088,272 dated May 25, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/023572 dated Jul. 6, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/033064 dated Aug. 31, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/033122 dated Aug. 31, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/040860 dated Oct. 2, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/041242 dated Nov. 17, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/041249 dated Oct. 2, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/042262 dated Oct. 14, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/043059 dated Oct. 6, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/044024 dated Nov. 12, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/046914 dated Dec. 1, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/055680 dated Dec. 15, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/057562 dated Jan. 27, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/061563 dated Feb. 19, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/065234 dated Apr. 12, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/067451 dated Mar. 25, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/067454 dated Mar. 29, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2020/067455 dated Mar. 26, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/015024 dated May 18, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/015787 dated May 27, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/023001 dated Jun. 21, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/024162 dated Jul. 8, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/026607 dated Jul. 29, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027061 dated Jul. 19, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027104 dated Jul. 6, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027314 dated Jul. 6, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027422 dated Aug. 12, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027425 dated Aug. 11, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027913 dated Jul. 12, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/027917 dated Aug. 19, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/035181 dated Sep. 16, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/043893 dated Nov. 22, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/044699 dated Nov. 22, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/045188 dated Jan. 26, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/047536 dated Dec. 23, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/048211 dated Dec. 22, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/048661 dated Feb. 14, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/049404 dated Jan. 18, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/051456 dated Jan. 19, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/053593 dated Apr. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/055515 dated Jan. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/056566 dated Feb. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/060993 dated Mar. 18, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2021/062440 dated Mar. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011108 dated Apr. 22, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011281 dated Apr. 25, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011419 dated Jun. 7, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/011421 dated Jun. 13, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/012794 dated May 3, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015471 dated May 16, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/016942 dated Jun. 8, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/018170 dated May 31, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/019254 dated Jun. 7, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/019480 dated Jun. 13, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/021103 dated Jun. 23, 2022. |
Issue Notification for U.S. Appl. No. 14/952,591 dated Jul. 28, 2021. |
Issue Notification for U.S. Appl. No. 17/088,272 dated Jun. 15, 2022. |
Issue Notification for U.S. Appl. No. 17/330,657 dated Jun. 22, 2022. |
Issue Notification for U.S. Appl. No. 29/624,661 dated Aug. 4, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/245,726 dated Jan. 21, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/433,773 dated Apr. 21, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/449,039 dated Dec. 8, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/452,145 dated Sep. 28, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/452,258 dated Sep. 28, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/478,180 dated Oct. 22, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/899,956 dated Sep. 2, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Oct. 5, 2021. |
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Apr. 27, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Jul. 22, 2021. |
Non-Final Office Action for U.S. Appl. No. 17/330,657 dated Aug. 11, 2021. |
Non-Final Office Action for U.S. Appl. No. 17/662,700 dated Jul. 22, 2022. |
Non-Final Office Action for U.S. Appl. No. 29/741,751 dated Jan. 18, 2022. |
Notice of Allowance for U.S. Appl. No. 14/952,591 dated Apr. 5, 2021. |
Notice of Allowance for U.S. Appl. No. 14/952,591 dated Jul. 8, 2021. |
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Apr. 19, 2022. |
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Dec. 29, 2021. |
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Aug. 5, 2021. |
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Mar. 4, 2022. |
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Nov. 24, 2021. |
Notice of Allowance for U.S. Appl. No. 17/330,657 dated Mar. 16, 2022. |
Notice of Allowance for U.S. Appl. No. 17/330,657 dated Nov. 26, 2021. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Apr. 28, 2021. |
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Apr. 29, 2021. |
Notice of Allowance for U.S. Appl. No. 29/741,751 dated Jun. 9, 2022. |
Restriction Requirement for U.S. Appl. No. 16/433,773 dated Dec. 7, 2021. |
Restriction Requirement for U.S. Appl. No. 16/478,180 dated May 25, 2021. |
U.S. Appl. No. 14/625,469, filed Feb. 28, 2015. |
U.S. Appl. No. 14/947,759, filed Nov. 20, 2015. |
U.S. Appl. No. 14/952,591, filed Nov. 25, 2015. |
U.S. Appl. No. 15/260,103, filed Sep. 8, 2016. |
U.S. Appl. No. 15/384,196, filed Dec. 19, 2016. |
U.S. Appl. No. 16/245,726, filed Jan. 11, 2019. |
U.S. Appl. No. 17/330,657, filed May 26, 2021. |
U.S. Appl. No. 17/378,015, filed Jul. 16, 2021. |
U.S. Appl. No. 17/394,055, filed Aug. 4, 2021. |
U.S. Appl. No. 17/412,864, filed Aug. 26, 2021. |
U.S. Appl. No. 17/444,825, filed Aug. 10, 2021. |
U.S. Appl. No. 17/446,256, filed Aug. 27, 2021. |
U.S. Appl. No. 17/446,654, filed Sep. 1, 2021. |
U.S. Appl. No. 17/447,123, filed Sep. 8, 2021. |
U.S. Appl. No. 17/450,864, filed Oct. 14, 2021. |
U.S. Appl. No. 17/451,345, filed Oct. 19, 2021. |
U.S. Appl. No. 17/451,354, filed Oct. 19, 2021. |
U.S. Appl. No. 17/453,260, filed Nov. 2, 2021. |
U.S. Appl. No. 17/453,560, filed Nov. 4, 2021. |
U.S. Appl. No. 17/461,036 dated Aug. 30, 2021. |
U.S. Appl. No. 17/494,578, filed Oct. 5, 2021. |
U.S. Appl. No. 17/501,591, filed Oct. 14, 2021. |
U.S. Appl. No. 17/595,747, filed Nov. 23, 2021. |
U.S. Appl. No. 17/597,408, filed Jan. 5, 2022. |
U.S. Appl. No. 17/597,673, filed Jan. 18, 2022. |
U.S. Appl. No. 17/614,173, filed Nov. 24, 2021. |
U.S. Appl. No. 17/631,619, filed Jan. 31, 2022. |
U.S. Appl. No. 17/645,821, filed Dec. 23, 2021. |
U.S. Appl. No. 17/646,771, filed Jan. 3, 2022. |
U.S. Appl. No. 17/653,314, filed Mar. 3, 2022. |
U.S. Appl. No. 17/653,920, filed Mar. 8, 2022. |
U.S. Appl. No. 17/654,156 filed Mar. 9, 2022. |
U.S. Appl. No. 17/655,464, filed Mar. 18, 2022. |
U.S. Appl. No. 17/657,474, filed Mar. 31, 2022. |
U.S. Appl. No. 17/661,090, filed Apr. 28, 2022. |
U.S. Appl. No. 17/662,700, filed May 10, 2022. |
U.S. Appl. No. 17/663,046, filed May 12, 2022. |
U.S. Appl. No. 17/664,914, filed May 25, 2022. |
U.S. Appl. No. 17/749,340, filed May 20, 2022. |
U.S. Appl. No. 17/754,736, filed Apr. 11, 2022. |
U.S. Appl. No. 17/756,201, filed May 19, 2022. |
U.S. Appl. No. 17/758,152, filed Jun. 29, 2022. |
U.S. Appl. No. 17/758,316, filed Jul. 1, 2022. |
U.S. Appl. No. 29/741,751, filed Jul. 15, 2020. |
U.S. Appl. No. 61/955,537, filed Mar. 19, 2014. |
U.S. Appl. No. 62/082,279, filed Nov. 20, 2014. |
U.S. Appl. No. 62/084,078, filed Nov. 25, 2014. |
U.S. Appl. No. 62/414,963, filed Oct. 31, 2016. |
U.S. Appl. No. 62/485,578, filed Apr. 14, 2017. |
U.S. Appl. No. 62/853,279, filed May 28, 2019. |
U.S. Appl. No. 62/853,889, filed May 29, 2019. |
U.S. Appl. No. 62/864,656, filed Jun. 21, 2019. |
U.S. Appl. No. 62/873,045, filed Jul. 11, 2019. |
U.S. Appl. No. 62/873,048, filed Jul. 11, 2019. |
U.S. Appl. No. 62/876,500, filed Jul. 19, 2019. |
U.S. Appl. No. 62/877,558, filed Jul. 23, 2019. |
U.S. Appl. No. 62/883,172, filed Aug. 6, 2019. |
U.S. Appl. No. 62/889,149, filed Aug. 20, 2019. |
U.S. Appl. No. 62/923,279, filed Oct. 18, 2019. |
U.S. Appl. No. 62/926,767, filed Oct. 28, 2019. |
U.S. Appl. No. 62/935,337, filed Nov. 14, 2019. |
U.S. Appl. No. 62/938,447, filed Nov. 21, 2019. |
U.S. Appl. No. 62/949,187, filed Dec. 17, 2019. |
U.S. Appl. No. 62/956,756, filed Jan. 3, 2020. |
U.S. Appl. No. 62/956,767, filed Jan. 3, 2020. |
U.S. Appl. No. 62/956,770, filed Jan. 3, 2020. |
U.S. Appl, No. 62/967,158, filed Jan. 26, 2020. |
U.S. Appl. No. 62/967,977, filed Jan. 30, 2020. |
U.S. Appl. No. 63/008,112, filed Apr. 10, 2020. |
U.S. Appl. No. 63/011,445, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,487, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,571, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,657, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,760, filed Apr. 17, 2020. |
U.S. Appl. No. 63/012,347, filed Apr. 20, 2020. |
U.S. Appl. No. 63/012,384, filed Apr. 20, 2020. |
U.S. Appl. No. 63/030,685, filed May 27, 2020. |
U.S. Appl. No. 63/033,310, filed Jun. 2, 2020. |
U.S. Appl. No. 63/047,374, filed Jul. 2, 2020. |
U.S. Appl. No. 63/061,241, filed Aug. 5, 2020. |
U.S. Appl. No. 63/061,244, filed Aug. 5, 2020. |
U.S. Appl. No. 63/061,834, filed Aug. 6, 2020. |
U.S. Appl. No. 63/064,017, filed Aug. 11, 2020. |
U.S. Appl. No. 63/064,126, filed Aug. 11, 2020. |
U.S. Appl. No. 63/067,542, filed Aug. 19, 2020. |
U.S. Appl. No. 63/071,438, filed Aug. 28, 2020. |
U.S. Appl. No. 63/071,821, filed Aug. 28, 2020. |
U.S. Appl. No. 63/073,545, filed Sep. 2, 2020. |
U.S. Appl. No. 63/073,553, filed Sep. 2, 2020. |
U.S. Appl. No. 63/074,051, filed Sep. 3, 2020. |
U.S. Appl. No. 63/074,066, filed Sep. 3, 2020. |
U.S. Appl. No. 63/076,032, filed Sep. 9, 2020. |
U.S. Appl. No. 63/076,474, filed Sep. 10, 2020. |
U.S. Appl. No. 63/076,477, filed Sep. 10, 2020. |
U.S. Appl. No. 63/082,261, filed Sep. 23, 2020. |
U.S. Appl. No. 63/088,506, filed Oct. 7, 2020. |
U.S. Appl. No. 63/088,511, filed Oct. 7, 2020. |
U.S. Appl. No. 63/088,539, filed Oct. 7, 2020. |
U.S. Appl. No. 63/094,464, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,498, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,594, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,608, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,626, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,646, filed Oct. 21, 2020. |
U.S. Appl. No. 63/109,066, filed Nov. 3, 2020. |
U.S. Appl. No. 63/109,084, filed Nov. 3, 2020. |
U.S. Appl. No. 63/112,417, filed Nov. 11, 2020. |
U.S. Appl. No. 63/119,161, filed Nov. 30, 2020. |
U.S. Appl. No. 63/124,271, filed Dec. 11, 2020. |
U.S. Appl. No. 63/133,892, filed Jan. 5, 2021. |
U.S. Appl. No. 63/134,450, filed Jan. 6, 2021. |
U.S. Appl. No. 63/134,631, filed Jan. 7, 2021. |
U.S. Appl. No. 63/134,754, filed Jan. 7, 2021. |
U.S. Appl. No. 63/138,878, filed Jan. 19, 2021. |
U.S. Appl. No. 63/146,946, filed Feb. 8, 2021. |
U.S. Appl. No. 63/147,013, filed Feb. 8, 2021. |
U.S. Appl. No. 63/147,299, filed Feb. 9, 2021. |
U.S. Appl. No. 63/154,248, filed Feb. 26, 2021. |
U.S. Appl. No. 63/155,395, filed Mar. 2, 2021. |
U.S. Appl. No. 63/157,007, filed Mar. 5, 2021. |
U.S. Appl. No. 63/157,014, filed Mar. 5, 2021. |
U.S. Appl. No. 63/159,142, filed Mar. 10, 2021. |
U.S. Appl. No. 63/159,186, filed Mar. 10, 2021. |
U.S. Appl. No. 63/159,210, filed Mar. 10, 2021. |
U.S. Appl. No. 63/159,280, filed Mar. 10, 2021. |
U.S. Appl. No. 63/165,273, filed Mar. 24, 2021. |
U.S. Appl. No. 63/165,384, filed Mar. 24, 2021. |
U.S. Appl. No. 63/171,165, filed Apr. 6, 2021. |
U.S. Appl. No. 63/172,975, filed Apr. 9, 2021. |
U.S. Appl. No. 63/181,695, filed Apr. 29, 2021. |
U.S. Appl. No. 63/191,558, filed May 21, 2021. |
U.S. Appl. No. 63/192,274, filed May 24, 2021. |
U.S. Appl. No. 63/192,289, filed May 24, 2021. |
U.S. Appl. No. 63/193,235, filed May 26, 2021. |
U.S. Appl. No. 63/193,406, filed May 26, 2021. |
U.S. Appl. No. 63/193,891, filed May 27, 2021. |
U.S. Appl. No. 63/208,262, filed Jun. 8, 2021. |
U.S. Appl. No. 63/214,551, filed Jun. 24, 2021. |
U.S. Appl. No. 63/214,570, filed Jun. 24, 2021. |
U.S. Appl. No. 63/215,017, filed Jun. 25, 2021. |
U.S. Appl. No. 63/228,244, filed Aug. 2, 2021. |
U.S. Appl. No. 63/228,252, filed Aug. 2, 2021. |
U.S. Appl. No. 63/228,258, filed Aug. 2, 2021. |
U.S. Appl. No. 63/230,894, filed Aug. 9, 2021. |
U.S. Appl. No. 63/230,897, filed Aug. 9, 2021. |
U.S. Appl. No. 63/238,457, filed Aug. 30, 2021. |
U.S. Appl. No. 63/238,477, filed Aug. 30, 2021. |
U.S. Appl. No. 63/241,562, filed Sep. 8, 2021. |
U.S. Appl. No. 63/241,564, filed Sep. 8, 2021. |
U.S. Appl. No. 63/241,575, filed Sep. 8, 2021. |
U.S. Appl. No. 63/246,972, filed Sep. 22, 2021. |
U.S. Appl. No. 63/247,375, filed Sep. 23, 2021. |
U.S. Appl. No. 63/247,478, filed Sep. 23, 2021. |
U.S. Appl. No. 63/247,491, filed Sep. 23, 2021. |
U.S. Appl. No. 63/299,208, filed Jan. 13, 2022. |
Boehringer CareDry System—Second Generation for Non-Invasive Urinary Management for Females, Mar. 2021, 3 pgs. |
“External Urine Management for Female Anatomy”, https://www.stryker.com/us/en/sage/products/sage-primafit.html, Jul. 2020, 4 pages. |
“Rising Warrior Insulated Gallon Jug Cover”, https://www.amazon.com/Rising-Warrior-Insulated-Sleeve, 2021, 2 pages. |
“Urine Bag Cover-Catheter Bag Cover 2000 ml Volume-Medline Style-Multiple Sclerosis-Spine Injury-Suprapublic Catheter-Bladder Incontinence”, https://www.etsy.com/listing/1142934658/urine-bag-cover-caatheter-bag-cover-2000, 2022, 1 page. |
“Vinyl Dust Cover, Janome #741811000, Janome, Sewing Parts Online”, https://www.sewingpartsonline.com/vinyl-dust-cover-janome-74181000, 2020, 2 pages. |
Ali , “Sustainability Assessment: Seventh Generation Diapers versus gDiapers”, The University of Vermont, Dec. 6, 2011, pp. 1-31. |
Autumn , et al., “Frictional adhesion: a new angle on gecko attachment”, The Journal of Experimental Biology, 2006, pp. 3569-3579. |
Cañas , et al., “Effect of nano- and micro-roughness on adhesion of bioinspired micropatterned surfaces”, Acta Biomaterialia 8, 2012, pp. 282-288. |
Chaudhary , et al., “Bioinspired dry adhesive: Poly(dimethylsiloxane) grafted with poly(2-ethylhexyl acrylate) brushes”, European Polymer Journal, 2015, pp. 432-440. |
Dai , et al., “Non-sticky and Non-slippery Biomimetic Patterned Surfaces”, Journal of Bionic Engineering, Mar. 2020, pp. 326-334. |
Espinoza-Ramirez , “Nanobiodiversity and Biomimetic Adhesives Development: From Nature to Production and Application”, Journal of Biomaterials and Nanobiotechnology, pp. 78-101, 2019. |
Hwang , et al., “Multifunctional Smart Skin Adhesive Patches for Advanced Health Care”, Adv. Healthcare Mater, 2018, pp. 1-20. |
Jagota , et al., “Adhesion, friction, and compliance of bio-mimetic and bio-inspired structured interfaces”, Materials Science and Engineering, 2011, pp. 253-292. |
Jeong , et al., “A nontransferring dry adhesive with hierarchical polymer nanohairs”, PNAS, Apr. 7, 2009, pp. 5639-5644. |
Jeong , et al., “Nanohairs and nanotubes: Efficient structural elements for gecko-inspired artificial dry adhesives”, Science Direct, 2009, pp. 335-346. |
Karp , et al., “Dry solution to a sticky problem”, Nature., 2011, pp. 42-43. |
Lee , et al., “Continuous Fabrication of Wide-Tip Microstructures for Bio-Inspired Dry Adhesives via Tip Inking Process”, Journal of Chemistry, Jan. 2, 2019, pp. 1-5. |
Parness , et al., “A microfabricated wedge-shaped adhesive array displaying gecko-like dynamic adhesion, directionality”, J.R. Soc. Interface, 2009, pp. 1223-1232. |
Tsipenyuk , et al., “Use of biomimetic hexagonal surface texture in friction against lubricated skin”, Journal of The Royal Society—Interface, 2014, pp. 1-6. |
Advisory Action for U.S. Appl. No. 16/433,773 dated Feb. 15, 2023. |
Advisory Action for U.S. Appl. No. 16/452,258 dated Oct. 26, 2022. |
Advisory Action for U.S. Application No. 16/478, 180 dated Sep. 21, 2022. |
Advisory Action for U.S. Appl. No. 17/662,700 dated Jan. 30, 2023. |
Advisory Action for U.S. Appl. No. 16/369,676 dated Mar. 24, 2023. |
Final Office Action for U.S. Appl. No. 16/245,726 dated Nov. 25, 2022. |
Final Office Action for U.S. Appl. No. 16/433,773 dated Oct. 25, 2022. |
Final Office Action for U.S. Appl. No. 16/449,039 dated Aug. 1, 2022. |
Final Office Action for U.S. Appl. No. 17/051,399 dated Mar. 9, 2023. |
Final Office Action for U.S. Appl. No. 17/662,700 dated Sep. 30, 2022. |
International Search Report and Written Opinion from International Application No. PCT/IB2021/057173 dated Nov. 5, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2021/039866 dated Oct. 7, 2021. |
International Search Report and Written Opinion from International Application No. PCT/US2022/014285 dated Sep. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/014749 dated Sep. 28, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015026 dated Oct. 31, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015045 dated Sep. 9, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015073 dated Sep. 8, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015418 dated Nov. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015420 dated Nov. 18, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015492 dated Apr. 26, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/015781 dated May 6, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/018159 dated Dec. 12, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/022111 dated Oct. 26, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/023594 dated Jul. 12, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/026667 dated Aug. 22, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/030685 dated Oct. 31, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/031032 dated Sep. 9, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/032424 dated Oct. 11, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/034457 dated Oct. 12, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/034744 dated Dec. 9, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039018 dated Jan. 10, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039022 dated Jan. 10, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039711 dated Jan. 12, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/039714 dated Nov. 22, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/042719 dated Dec. 5, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/042725 dated Dec. 19, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044107 dated Dec. 23, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044212 dated Jan. 20, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044243 dated Feb. 24, 2023. |
Issue Notification for U.S. Appl. No. 16,905,400 dated Nov. 30, 2022. |
Non-Final Office Action for U.S. Appl. No. 16/452, 145 dated Mar. 28, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/478, 180 dated Dec. 20, 2022. |
Non-Final Office Action for U.S. Appl. No. 17/051,550 dated Dec. 15, 2022. |
Non-Final Office Action for U.S. Appl. No. 17/051,585 dated Mar. 29, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/444,792 dated Feb. 10, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/448,811 dated Mar. 1, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/451,345 dated Dec. 7, 2022. |
Non-Final Office Action for U.S. Appl. No. 17/655,464 dated Mar. 14, 2023. |
Non-Final Office Action on U.S. Appl. No. 16/904,868 dated Mar. 15, 2023. |
Notice of Allowance for U.S. Appl. No. 17/662,700 dated Mar. 28, 2023. |
Notice of Allowance for U.S. Appl. No. 17/663,046 dated Jan. 30, 2023. |
Restriction Requirement for U.S. Appl. No. 17/446,256 dated Jan. 23, 2023. |
Text Messages to Lorena Eckert Re Prototype PureWick Holder dated Apr. 16, 2022. |
U.S. Appl. No. 17/759,697, filed Jul. 28, 2022. |
U.S. Appl. No. 17/878,268, filed Aug. 1, 2022. |
U.S. Appl. No. 17/907,125, filed Sep. 23, 2022. |
U.S. Appl. No. 17/912,147, filed Sep. 16, 2022. |
U.S. Appl. No. 17/929,887, filed Sep. 6, 2022. |
U.S. Appl. No. 17/930,238, filed Sep. 7, 2022. |
U.S. Appl. No. 17/933,590, filed Sep. 20, 2022. |
U.S. Appl. No. 17/996,064, filed Oct. 12, 2022. |
U.S. Appl. No. 17/996,155, filed Oct. 13, 2022. |
U.S. Appl. No. 17/996,253, filed Oct. 14, 2022. |
U.S. Appl. No. 17/996,468, filed Oct. 18, 2022. |
U.S. Appl. No. 17/996,556, filed Oct. 19, 2022. |
U.S. Appl. No. 18/003,029, filed Dec. 22, 2022. |
U.S. Appl. No. 18/006,807, filed Jan. 25, 2023. |
U.S. Appl. No. 18/007,105, filed Jan. 27, 2023. |
U.S. Appl. No. 18/041,109, filed Feb. 9, 2023. |
U.S. Appl. No. 18/042,842, filed Feb. 24, 2023. |
U.S. Appl. No. 18/043,618, filed Mar. 1, 2023. |
U.S. Appl. No. 18/115,444, filed Feb. 28, 2023. |
U.S. Appl. No. 18/164,800, filed Feb. 6, 2023. |
U.S. Appl. No. 18/246,121, filed Mar. 21, 2023. |
U.S. Appl. No. 62/991,754, filed Mar. 19, 2020. |
U.S. Appl. No. 63/241,328, filed Sep. 7, 2021. |
U.S. Appl. No. 63/308,190, filed Feb. 9, 2022. |
Advisory Action for U.S. Appl. No. 16/245,726 dated Apr. 19, 2023. |
Final Office Action for U.S. Appl. No. 16/478,180 dated May 31, 2023. |
Final Office Action for U.S. Appl. No. 17/051,550 dated May 23, 2023. |
Final Office Action for U.S. Appl. No. 17/051,585 dated Jul. 27, 2023. |
Final Office Action for U.S. Appl. No. 17/444,792 dated Jun. 15, 2023. |
Final Office Action for U.S. Appl. No. 17/448,811 dated Aug. 3, 2023. |
Final Office Action for U.S. Appl. No. 17/451,345 dated May 3, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/041688 dated Nov. 21, 2022. |
International Search Report and Written Opinion from International Application No. PCT/US2022/043818 dated Mar. 24, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/044208 dated May 8, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/049300 dated Jun. 6, 2023. |
Issue Notification for U.S. Appl. No. 16/899,956 dated Mar. 29, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/433,773 dated Apr. 11, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/449,039 dated Apr. 27, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/452,258 dated Apr. 26, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/051,399 dated Aug. 18, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/179,116 dated Mar. 24, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/326,980 dated Jul. 11, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/446,256 dated Apr. 13, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/450,864 dated May 10, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/451,354 dated May 3, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/453,260 dated Mar. 14, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/501,591 dated Apr. 25, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/646,771 dated Jul. 5, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/653,137 dated Apr. 7, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/661,090 dated Jul. 6, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/663,330 dated Jun. 29, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/664,487 dated Jun. 8, 2023. |
Non-Final Office Action for U.S. Appl. No. 18/139,523 dated Aug. 17, 2023. |
Notice of Allowance for U.S. Appl. No. 16/245,726 dated Jul. 6, 2023. |
Notice of Allowance for U.S. Appl. No. 17/051,554 dated Jul. 6, 2023. |
Notice of Allowance for U.S. Appl. No. 17/461,036 dated Jun. 30, 2023. |
Notice of Allowance for U.S. Appl. No. 17/662,700 dated Jul. 28, 2023. |
Notice of Allowance for U.S. Appl. No. 18/299,788 mailed Jul. 24, 2023. |
Notice of Allowance for U.S. Appl. No. 18/299,788 dated Jul. 24, 2023. |
Restriction Requirement for U.S. Appl. No. 17/326,980 dated Mar. 20, 2023. |
Restriction Requirement for U.S. Appl. No. 17/645,821 dated Jul. 12, 2023. |
Restriction Requirement for U.S. Appl. No. 17/646,771 dated Apr. 6, 2023. |
Restriction Requirement for U.S. Appl. No. 17/657,474 dated Jun. 30, 2023. |
U.S. Appl. No. 15/611,587, filed Jun. 1, 2017. |
U.S. Appl. No. 15/612,325, filed Jun. 2, 2017. |
U.S. Appl. No. 17/664,487, filed May 23, 2022. |
U.S. Appl. No. 18/134,857, filed Apr. 14, 2023. |
U.S. Appl. No. 18/140,163, filed Apr. 27, 2023. |
U.S. Appl. No. 18/140,751, filed Apr. 28, 2023. |
U.S. Appl. No. 18/198,464, filed May 17, 2023. |
U.S. Appl. No. 18/247,986, filed Apr. 5, 2023. |
U.S. Appl. No. 18/259,626, filed Jun. 28, 2023. |
U.S. Appl. No. 18/260,122, filed Jun. 30, 2023. |
U.S. Appl. No. 18/260,391, filed Jul. 5, 2023. |
U.S. Appl. No. 18/260,394, filed Jul. 5, 2023. |
U.S. Appl. No. 18/263,800, filed Aug. 1, 2023. |
U.S. Appl. No. 18/264,004, filed Aug. 2, 2023. |
U.S. Appl. No. 18/265,736, filed Jun. 7, 2023. |
U.S. Appl. No. 18/299,788, filed Apr. 13, 2023. |
U.S. Appl. No. 18/335,579, filed Jun. 15, 2023. |
U.S. Appl. No. 63/150,640, filed Feb. 18, 2021. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 5, Apr. 1, 2022, 72 pages. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 1, Mar. 28, 2022, 99 pages. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 2, Mar. 29, 2022, 106 pages. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 3, Mar. 30, 2022, 115 pages. |
PureWick Corporation v. Sage Products, LLC Transcripts vol. 4, Mar. 31, 2022, 117 pages. |
“AMXD Control Starter Kit”, Omni Medical Systems, Inc., 1 page. |
“AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical, Jan. 11, 2010, 10 pages. |
“AMXDmax Development History 2002-2014”, Omni Medical Systems, Inc., 2 pages. |
“Combat Force Multiplier in Flight Bladder Relief Cockpit Essential Equipment Brochure”, Omni Medical, 20 pages. |
“GSA Price List”, Omni Medical, Apr. 2011, 2 pages. |
“How is Polypropylene Fiber Made”, https:www.yarnsandfibers.com/textile-resources/synthetic-fibers/polypropylene-fiber/polypropylene-fiber-production-raw-materials/how-is-polypropylene-fiber-made/ last accessed 2020, Oct. 7, 2020, 3 pages. |
“Letter to Mark Harvie of Omni Measurement Systems”, Department of Veterans Affairs, Nov. 1, 2007, 11 pages. |
“Revised AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical Systems, Oct. 8, 2019, 52 pages. |
Pieper , et al., “An external urine-collection device for women: A clinical trial”, Journal of ER Nursing, vol. 20, No. 2, Mar./Apr. 1993, pp. 51-55. |
Vinas , “A Solution for an Awkward—But Serious—Subject”, http://www.aero-news.net/index.cfm?do=main.textpost&id=69ae2bb1-838b-4098-a7b5-7flbb2505688 last accessed Feb. 8, 2021, 3 pages. |
Advisory Action for U.S. Appl. No. 16/433,773 mailed Dec. 29, 2023. |
Advisory Action for U.S. Appl. No. 16/449,039 mailed Jan. 25, 2024. |
Advisory Action for U.S. Appl. No. 16/478,180 mailed Sep. 7, 2023. |
Advisory Action for U.S. Appl. No. 16/904,868 mailed Jan. 2, 2024. |
Advisory Action for U.S. Appl. No. 17/051,550 mailed Sep. 8, 2023. |
Advisory Action for U.S. Appl. No. 17/051,585 mailed Oct. 17, 2023. |
Advisory Action for U.S. Appl. No. 17/179,116 mailed Jan. 8, 2024. |
Advisory Action for U.S. Appl. No. 17/444,792 mailed Aug. 25, 2023. |
Advisory Action for U.S. Appl. No. 17/446,256 mailed Dec. 8, 2023. |
Advisory Action for U.S. Appl. No. 17/448,811 mailed Nov. 15, 2023. |
Advisory Action for U.S. Appl. No. 17/451,345 mailed Oct. 20, 2023. |
Advisory Action for U.S. Appl. No. 17/451,354 mailed Jan. 30, 2024. |
Advisory Action for U.S. Appl. No. 17/453,260 mailed Dec. 22, 2023. |
Advisory Action for U.S. Appl. No. 17/653,137 mailed Dec. 1, 2023. |
Advisory Action for U.S. Appl. No. 17/655,464 mailed Dec. 13, 2023. |
Communication of Notice of Opposition of European Application No. 17807547.9 mailed Jan. 5, 2024. |
Final Office Action for U.S. Appl. No. 16/433,773 mailed Oct. 10, 2023. |
Final Office Action for U.S. Appl. No. 16/449,039 mailed Nov. 21, 2023. |
Final Office Action for U.S. Appl. No. 16/452,258 mailed Dec. 21, 2023. |
Final Office Action for U.S. Appl. No. 16/904,868 mailed Nov. 2, 2023. |
Final Office Action for U.S. Appl. No. 17/051,399 mailed Jan. 8, 2024. |
Final Office Action for U.S. Appl. No. 17/179,116 mailed Oct. 31, 2023. |
Final Office Action for U.S. Appl. No. 17/446,256 mailed Sep. 19, 2023. |
Final Office Action for U.S. Appl. No. 17/446,654 mailed Jan. 31, 2024. |
Final Office Action for U.S. Appl. No. 17/450,864 mailed Dec. 28, 2023. |
Final Office Action for U.S. Appl. No. 17/451,354 mailed Oct. 30, 2023. |
Final Office Action for U.S. Appl. No. 17/453,260 mailed Oct. 5, 2023. |
Final Office Action for U.S. Appl. No. 17/501,591 mailed Nov. 14, 2023. |
Final Office Action for U.S. Appl. No. 17/646,771 mailed Dec. 21, 2023. |
Final Office Action for U.S. Appl. No. 17/653,137 mailed Sep. 21, 2023. |
Final Office Action for U.S. Appl. No. 17/655,464 mailed Sep. 1, 2023. |
Final Office Action for U.S. Appl. No. 17/661,090 mailed Dec. 11, 2023. |
Final Office Action for U.S. Appl. No. 17/663,330 mailed Dec. 12, 2023. |
Final Office Action for U.S. Appl. No. 17/664,487 mailed Jan. 4, 2024. |
Final Office Action for U.S. Appl. No. 18/139,523 mailed Dec. 22, 2023. |
Final Office Action for U.S. Appl. No. 18/140,751 mailed Jan. 17, 2024. |
Final Office Action for U.S. Appl. No. 18/164,800 mailed Dec. 6, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2022/050909 mailed Jul. 24, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2023/012696 mailed Jul. 6, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2023/018474 mailed Sep. 11, 2023. |
International Search Report and Written Opinion from International Application No. PCT/US2023/024805 mailed Dec. 14, 2023. |
Issue Notification for U.S. Appl. No. 16/245,726 mailed Oct. 18, 2023. |
Issue Notification for U.S. Appl. No. 17/461,036 mailed Oct. 11, 2023. |
Issue Notification for U.S. Appl. No. 17/663,046 mailed Dec. 20, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/452,145 mailed Nov. 2, 2023. |
Non-Final Office Action for U.S. Appl. No. 16/478,180 mailed Nov. 7, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/051,550 mailed Oct. 24, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/051,585 mailed Jan. 8, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/051,600 mailed Jan. 17, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/444,792 mailed Nov. 17, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/446,654 mailed Sep. 8, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/447,123 mailed Jan. 24, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/448,811 mailed Jan. 17, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/451,345 mailed Jan. 17, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/453,560 mailed Oct. 16, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/645,821 mailed Oct. 25, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/653,137 mailed Jan. 18, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/657,474 mailed Sep. 12, 2023. |
Non-Final Office Action for U.S. Appl. No. 17/664,914 mailed Jan. 31, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/808,354 mailed Nov. 28, 2023. |
Non-Final Office Action for U.S. Appl. No. 18/134,857 mailed Jan. 25, 2024. |
Non-Final Office Action for U.S. Appl. No. 18/140,163 mailed Nov. 9, 2023. |
Non-Final Office Action for U.S. Appl. No. 18/140,751 mailed Sep. 14, 2023. |
Non-Final Office Action for U.S. Appl. No. 18/198,464 mailed Dec. 7, 2023. |
Notice of Allowance for U.S. Appl. No. 17/051,554 mailed Oct. 18, 2023. |
Notice of Allowance for U.S. Appl. No. 17/326,980 mailed Jan. 29, 2024. |
Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Nov. 15, 2023. |
Notice of Allowance for U.S. Appl. No. 18/299,788 mailed Nov. 6, 2023. |
Restriction Requirement for U.S. Appl. No. 17/051,600 mailed Sep. 21, 2023. |
Restriction Requirement for U.S. Appl. No. 18/134,857 mailed Oct. 23, 2023. |
Submission in Opposition Proceedings for European Application No. 17807547.9 filed Jan. 10, 2024. |
U.S. Appl. No. 17/451,719, filed Oct. 19, 2021. |
U.S. Appl. No. 18/294,370, filed Feb. 1, 2024. |
U.S. Appl. No. 18/294,403, filed Feb. 1, 2024. |
U.S. Appl. No. 18/373,424, filed Sep. 27, 2023. |
U.S. Appl. No. 18/376,274, filed Oct. 3, 2023. |
U.S. Appl. No. 18/389,009, filed Nov. 13, 2023. |
U.S. Appl. No. 18/415,080, filed Jan. 17, 2024. |
U.S. Appl. No. 18/426,795, filed Jan. 30, 2024. |
U.S. Appl. No. 18/548,152 filed Aug. 28, 2023. |
U.S. Appl. No. 18/549,387, filed Sep. 7, 2023. |
U.S. Appl. No. 18/549,658, filed Sep. 8, 2023. |
U.S. Appl. No. 18/553,625, filed Oct. 2, 2023. |
U.S. Appl. No. 18/556,945, filed Oct. 24, 2023. |
U.S. Appl. No. 18/558,502, filed Nov. 1, 2023. |
U.S. Appl. No. 18/562,626, filed Nov. 20, 2023. |
U.S. Appl. No. 18/563,672, filed Nov. 22, 2023. |
U.S. Appl. No. 18/569,711, filed Dec. 13, 2023. |
U.S. Appl. No. 18/569,778, filed Dec. 13, 2023. |
U.S. Appl. No. 63/596,012, filed Nov. 3, 2023. |
U.S. Appl. No. 63/608,553, filed Dec. 11, 2023. |
Merriam-Webster Dictionary, “Embed Definition & Meaning”, https://www.merriam-webster.com/dictionary/embed last accessed Aug. 3, 2023 , 2003. |
Wikipedia Article, “Zylinder (Geometrie)”, https://de.wikipedia.org/w/index.php?title=Zylinder (Geometrie)&oldid=154862081, version of Jun. 1, 2016, 7 pages. |
Advisory Action for U.S. Appl. No. 16/452,258 mailed Apr. 8, 2024. |
Advisory Action for U.S. Appl. No. 17/446,654 mailed Apr. 15, 2024. |
Advisory Action for U.S. Appl. No. 17/450,864 mailed Mar. 21, 2024. |
Advisory Action for U.S. Appl. No. 17/501,591 mailed Feb. 22, 2024. |
Advisory Action for U.S. Appl. No. 17/646,771 mailed Feb. 29, 2024. |
Advisory Action for U.S. Appl. No. 17/661,090 mailed Feb. 26, 2024. |
Advisory Action for U.S. Appl. No. 17/663,330 mailed Feb. 27, 2024. |
Advisory Action for U.S. Appl. No. 17/664,487 mailed Mar. 13, 2024. |
Advisory Action for U.S. Appl. No. 18/139,523 mailed Apr. 24, 2024. |
Advisory Action for U.S. Appl. No. 18/140,751 mailed Apr. 24, 2024. |
Advisory Action for U.S. Appl. No. 18/164,800 mailed Feb. 12, 2024. |
Corrected Notice of Allowability for U.S. Appl. No. 17/326,980 mailed Feb. 8, 2024. |
Corrected Notice of Allowability for U.S. Appl. No. 17/657,474 mailed Mar. 13, 2024. |
Corrected Notice of Allowability for U.S. Appl. No. 17/657,474 mailed May 14, 2024. |
Final Office Action for U.S. Appl. No. 16/478,180 mailed Feb. 28, 2024. |
Final Office Action for U.S. Appl. No. 17/444,792 mailed Apr. 3, 2024. |
Final Office Action for U.S. Appl. No. 17/447,123 mailed May 14, 2024. |
Final Office Action for U.S. Appl. No. 17/451,345 mailed Apr. 18, 2024. |
Final Office Action for U.S. Appl. No. 17/645,821 mailed Apr. 3, 2024. |
Final Office Action for U.S. Appl. No. 17/808,354 mailed Apr. 10, 2024. |
Final Office Action for U.S. Appl. No. 18/140,163 mailed Mar. 27, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/025192 mailed Feb. 7, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/025939 mailed Feb. 7, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/030365 mailed Mar. 13, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/030373 mailed Mar. 13, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/031433 mailed Mar. 4, 2024. |
International Search Report and Written Opinion from International Application No. PCT/US2023/031740 mailed Mar. 4, 2024. |
Issue Notification for U.S. Appl. No. 17/051,550 mailed Mar. 13, 2024. |
Issue Notification for U.S. Appl. No. 17/051,554 mailed Mar. 6, 2024. |
Issue Notification for U.S. Appl. No. 18/299,788 mailed Feb. 21, 2024. |
Non-Final Office Action for U.S. Appl. No. 16/433,773 mailed Feb. 26, 2024. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 mailed Mar. 12, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/179,116 mailed Feb. 26, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/446,256 mailed Feb. 13, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/451,354 mailed Apr. 4, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/597,673 mailed Mar. 20, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/646,771 mailed Apr. 24, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/653,920 mailed Mar. 15, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/655,464 mailed Mar. 26, 2024. |
Non-Final Office Action for U.S. Appl. No. 17/661,090 mailed May 22, 2024. |
Non-Final Office Action for U.S. Appl. No. 18/003,029 mailed Mar. 26, 2024. |
Non-Final Office Action for U.S. Appl. No. 18/164,800 mailed Mar. 22, 2024. |
Non-Final Office Action for U.S. Appl. No. 18/389,009 mailed May 24, 2024. |
Notice of Allowance for U.S. Appl. No. 16/449,039 mailed Mar. 28, 2024. |
Notice of Allowance for U.S. Appl. No. 17/051,550 mailed Feb. 7, 2024. |
Notice of Allowance for U.S. Appl. No. 17/326,980 mailed Apr. 5, 2024. |
Notice of Allowance for U.S. Appl. No. 17/453,260 mailed Apr. 8, 2024. |
Notice of Allowance for U.S. Appl. No. 17/453,560 mailed Jan. 31, 2024. |
Notice of Allowance for U.S. Appl. No. 17/657,474 mailed Mar. 5, 2024. |
Notice of Allowance for U.S. Appl. No. 17/657,474 mailed May 2, 2024. |
Notice of Allowance for U.S. Appl. No. 17/662,700 mailed Mar. 6, 2024. |
Notice of Allowance for U.S. Appl. No. 18/198,464 mailed Apr. 17, 2024. |
Restriction Requirement for U.S. Appl. No. 17/667,097 mailed Mar. 20, 2024. |
Supplemental Notice of Allowance for U.S. Appl. No. 17/051,550 mailed Feb. 21, 2024. |
Supplemental Notice of Allowance for U.S. Appl. No. 17/051,554 mailed Feb. 14, 2024. |
U.S. Appl. No. 17/444,792, filed Aug. 10, 2021. |
U.S. Appl. No. 18/249,577, filed Oct. 19, 2021. |
U.S. Appl. No. 18/584,002, filed Feb. 22, 2024. |
U.S. Appl. No. 18/610,523, filed Mar. 20, 2024. |
U.S. Appl. No. 18/662,216, filed May 13, 2024. |
U.S. Appl. No. 18/681,987, filed Feb. 7, 2024. |
U.S. Appl. No. 18/682,006, filed Feb. 7, 2024. |
U.S. Appl. No. 18/687,117, filed Feb. 27, 2024. |
U.S. Appl. No. 18/688,023, filed Feb. 29, 2024. |
U.S. Appl. No. 18/693,638, filed Mar. 20, 2024. |
U.S. Appl. No. 18/694,090, filed Mar. 21, 2024. |
U.S. Appl. No. 63/561,893, filed Dec. 11, 2023. |
Wikipedia Article, “Decibel”, https://web.archive.org/web/2020041521917/https://en.wikipedia/org/wiki/Decibel last accessed Mar. 11, 2024, 21 pages. |
Wikipedia Article, “Fiberglass”, https://web.archive.org.web/20200309194847/https://en.wikipedia.org/wiki/Fiberglass last accessed Mar. 11, 2024. |
Number | Date | Country | |
---|---|---|---|
20190224036 A1 | Jul 2019 | US |
Number | Date | Country | |
---|---|---|---|
62485578 | Apr 2017 | US | |
62414963 | Oct 2016 | US | |
62084078 | Nov 2014 | US | |
62082279 | Nov 2014 | US | |
61955537 | Mar 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16245726 | Jan 2019 | US |
Child | 16369676 | US | |
Parent | 15611587 | Jun 2017 | US |
Child | 16245726 | US | |
Parent | PCT/US2016/049274 | Aug 2016 | WO |
Child | 15260103 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15260103 | Sep 2016 | US |
Child | 15611587 | US | |
Parent | 15171968 | Jun 2016 | US |
Child | PCT/US2016/049274 | US | |
Parent | 14952591 | Nov 2015 | US |
Child | 15260103 | US | |
Parent | 14947759 | Nov 2015 | US |
Child | 15260103 | US | |
Parent | 14625469 | Feb 2015 | US |
Child | 15260103 | US |